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ABSTRACT
THE REGULATION OF THE TRANSFERRIN RECEPTOR
BY INDUCERS OF CELLULAR DIFFERENTIATION
AND BY ANTISENSE PHOSPHOROTfflOATE OLIGODEOXYNUCLEOTIDES

P e te r T.C. Ho
Yale U niversity
1990

Modulation of surface transferrin receptor (TfR) activity has been associated
with leukemia cell differentiation and proliferation. To examine the mechanisms
involved in regulating this event, surface receptor protein and mENA levels were
measured in HL-60 promyelocytic leukemia cells induced to differentiate along the
myelocytic and monocytic pathways. Surface TfR down-regulation which occurs
during granulocytic differentiation by dimethylsulfoxide, retinoic acid, or
aclacinomycin A appears to be kinetically compatible with reduced biosynthesis
resulting from reductions in the level of steady-state mRNA.

In contrast,

biosynthetic modulation does not appear to mediate the initial surface receptor
down-regulation

seen

during

12-0-tetradecanoylphorbol-13-acetate-induced

macrophagic differentiation. However, a reduction in levels of receptor message
appears to contribute to the maintenance of diminished surface TfR activity in
these 12-0-tetradecanoylphorbol-13-acetate-treated cells.

The down-regulation of

surface TfR, in contrast, is not an early event during monocytic differentiation by
la,25-dihydroxyvitamin D3.

This apparently anomalous observation may be

explained by the fact that this agent does not induce "terminal differentiation" by
its strictest definition, since induced cells may not exhibit the loss of proliferative
capacity.
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A common feature of myelocytic and monocytic differentiating cells is the
complete inhibition of cellular proliferation observed within 10 to 16 hours
following a four-fold reduction in surface TfR. We conclude that the early decline
in surface TfR levels precludes its regulation as a consequence of the decrease in
proliferation, but rather implicates its role in the programmed cessation of growth
which is requisite for the terminal differentiation of these cells. Thus, the TfR
appears to be an important component of the genetic changes underlying leukemic
cell differention; however, its precise role within this framework of cellular
mediators and processes critical to the maturation process remains to be fully
elucidated.
One potential strategy to probe the role of TfR in leukemia cell
differentiation involves the use of specific agents which, ideally, modulate the
cellular homeostasis of TfR, but lack disparate biochemical activities within the
cell. Antisense oligodeoxynucleotides, which have emerged as novel and specific
inhibitors of gene expression, seem uniquely suited for this purpose. A series of
phosphodiester and phosphorothioate antisense oligonucleotides were synthesized
against the human TfR.

The phosphorothioate analogues exhibited marked

biological efficacy in culture, as assessed by inhibition of surface TfR content and
HL-60 growth, whereas their unmodified phosphodiester counterparts were
ineffective. Phosphorothioate oligonucleotides were more resistant to hydrolysis by
serum and cellular nucleases, and were more readily taken up by cells than the
phosphodiesters, thus providing a partial explanation for the differences in
biological activity. A length effect was observed, with antisense 30-mers exhibiting
greater TfR inhibitory activity than 17-iners.

The degree of surface receptor

inhibition observed, however, was not strictly sequence dependent. This suggested
that the phosphorothioate oligonucleotides may be biologically active in eukaryotic
cells by processes other than classical antisense complementary binding to mRNA.
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INTRODUCTION

The study of leukemia cell differentiation serves two distinct purposes.
First, it enhances the understanding of the endogenous process of cellular
maturation. Second, it may expedite the development of an alternative means of
cancer chemotherapy based upon the mimicry of the natural process of cellular
maturation and senescence rather than cytodestruction.

The latter objective,

however, requires that the cellular processes critical to the induction of
differentiation be first identified and characterized.

Down-regulation of the

transferrin receptor (TfR) has been proposed to be such a process. The expression
of this receptor, in addition to regulating intracellular iron homeostasis, appears
to modulate cellular growth and differentiation and is affected by a host of positive
and negative regulatory elements.

It is unclear, however, whether the down-

regulation of TfR, a common feature seen during the induction of differentiation
of a variety of model systems, is an event crucial for phenotypic maturation.
Alternatively, this event may underlie the cessation of proliferation which is, by
definition, part of the terminal differentiation process.

The elucidation of this

question requires more specific agents than the commonly used inducers of
differentiation which have pleiotropic actions. An ideal agent should modulate TfR
expression

alone

without affecting other

cellular processes.

Antisense

oligodeoxynucleotides are appropriate candidates for such analyses since they may,
in theory, be directed against the expression of a single gene within a cell.

H istorical Aspects of th e HL-60 Cell lin e .
The HL-60 cell line has served as one of the primary model systems for in
vitro studies of cell proliferation and differentiation since its isolation from a 351
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year old leukemia patient over ten years ago (1). Although originally classified
as an acute promyelocytic leukemia (FAB class M3), more recent evaluation of the
original histological specimens suggests a more proper classification of "acute
myeloblastic leukemia with maturation" (FAB class M2) (2).

Regardless of the

pathological taxonomy, the importance of this cell line as a biological model system
is underscored by its over 700 citations in the literature including two recent
reviews (3,4).
The phenotypic attributes of HL-60 cells are well defined. These cells grow
in suspension culture with a doubling time of 20 to 45 hours.

The line is

characterized by a myeloblastic or promyelocytic morphology with large blast-like
nuclei and a basophilic cytoplasm containing azurophilic granules. Histochemically,
uninduced HL-60 cells stain positively for myeloperoxidase and acid phosphatase.
At the surface membrane level, cells express receptors for transferrin, insulin, and
complement.

The importance of transferrin and insulin receptor expression is

denoted by the fact that HL-60 cells can proliferate and differentiate normally in
serum-free media formulations provided that insulin, transferrin, and selenium are
present.
The nuclear composition of HL-60 cells is clearly abnormal with a variety
of genetic anomalies reported.

Its chromosomal ploidy shows marked subline

variability with monosomic, trisomic, and tetrasomic karyotypes seen. One of the
most intensely studied genetic alterations and also the first observed in HL-60 cells
is a marked amplification of the c-myc oncogene (5). Although initially estimated
as being amplified 30-fold, later analyses indicated extensive subline variability
with some lines expressing only a 4-fold increase (6). Mutations at two other
genetic loci with presumed importance to the growth of leukemia cells have been
found. One allele for the GM-CSF gene is rearranged and partially deleted (7).
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An N-ras oncogene with a point mutation at codon 61 has demonstrated
transformation potential in the NIH3T3 transfection assay (8).

HL-60 as a Model System for C ellular D ifferentiation.
One of the most intriguing properties of the HL-60 line is its ability to
differentiate in response to a diverse variety of natural and synthetic compounds.
Greater than 90% of the population can mature to either granulocyte-like or
monocyte/macrophage-like elements depending on the inducing agent employed.
More detailed discussions concerning the pharmacology of differentiation inducers
may be found in a recent review by Hickman (9).

The in vitro assays which

confirm lineage-specific cellular differentiation (described in detail below) include
histology/morphology, the appearance of enzymatic markers or membrane proteins,
and biological behavior.
One maturation pathway available to HL-60 cells is along the granulocytic
lineage. Classically, the most commonly used inducers of this pathway are the
polar-planar compound, dimethyl sulfoxide (DMSO) (10, reviewed in Ref. 11), and
the vitamin A analogue, fl-all-trans-retinoic acid (RA) (12). Other agents in this
category include 6-thioguanine (13), methotrexate (14), actinomycin D (12, 13), and
the anthracyclines, aclacinomycin A and marcellomycin (15). Cells induced by the
above agents exhibit incomplete maturation toward granulocytes as evidenced by
Wright-Giemsa staining which reveals a population of metamyelocytes and band
cells rather than fully differentiated polymorphonuclear neutrophils. Nevertheless,
these compounds do induce terminal differentiation of HL-60 cells since induced
cells irreversibly lose their proliferative capacity.
The second maturation pathway available to HL-60 cells is along the
monocyte/macrophage lineage. The commonly used inducers in this group include
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the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) (16, reviewed in Ref.
17), and the vitamin, la,25-dihydroxyvitamin Ds (18). Although commonly thought
to be equivalent since both are identified by the appearance of non-specific esterase
(NSE) activity, macrophagic and monocytic differentiation are phenotypically quite
distinct. In direct contrast with la,25-dihydroxyvitamin D3-induced monocyte-like
cells, TPA-induced macrophage-like cells rapidly acquire adherence to plastic, but
do not exhibit nitroblue tetrazolium (NBT) reducing capacity. In addition, TPAtreated cells rapidly lose proliferative capacity, whereas monocytic HL-60
maturation is not necessarily accompanied by the loss of growth potential, hence
cannot be definitively designated as "terminal differentiation."
It has been noted previously that substantial subline variability with regard
to many parameters exists in the HL-60 line. The biological response to inducers
of differentiation is no exception. Some clones have shown equivalent response to
optimal concentrations of DMSO or RA (12).

Other groups report 90%

differentiation with DMSO, but only 60% maturation with RA (4).

Still other

groups show a greater response to RA than DMSO.
The plethora of assays and biological events characteristic of each lineage
of HL-60 differentiation has been summarized by Collins (3).

Classically, the

appearance of NBT activity heralds granulocytic or monocytic differentiation. In
this assay, mature cells respond to the addition of TPA with a respiratory burst
characterized by the conversion of oxygen to superoxide anion; this allows reduction
of the dye, nitroblue tetrazolium, to an insoluble blue/black formazan salt. The
induction of NSE activity is used to assess monocytic or macrophagic
differentiation.

This histochemical assay, in contrast with its name, is quite

specific for macrophages which respond with pink/red cytoplasmic staining. The
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kinetics of the appearance of these differentiation markers may vary according to
the inducer employed.
A variety of events occur at the cell membrane during cellular maturation.
Transferrin receptor down-regulation is a hallmark of terminal differentiation,
regardless of lineage. The Fc and complement receptors are typically increased
with granulocytic, monocytic, or macrophagic maturation. Chemotactic receptors
increase with granulocytic and monocytic induction, but are lost in macrophage
like cells.

The insulin receptor increases with monocytic differentiation, but

declines during granulocytic differentiation. Finally, differentiation can be assessed
by functional criteria reminiscent of the completely mature normal cellular
counterpart. Macrophage-like cells adhere to plastic. HL-60 induced along the
granulocyte, monocyte, or macrophage pathways acquire the ability to phagocytose
latex beads or yeast particles.

O ther Model System s of C ellular D ifferentiation.
The complexity and ubiquity of the differentiation process has spawned the
development of other model systems in addition to the HL-60 cell line. The U937 cell line (19) which matures along the macrophage lineage in response to TPA,
and the K-562 cell line (20) which can be induced along the erythroid pathway by
hemin are additional examples of inducible human leukemias.

The Friend

erythroid (21), the WEHI-3B D+ monomyelocytic (22), and the Ml myeloid (23)
leukemia cell lines are examples of murine differentiation models. Although solid
tumors represent the more common clinical oncological entities, they are
underrepresented in terms of in vitro models of differentiation.

Nevertheless,

established cell lines derived from embryonal cell carcinomas, neuroblastomas,
melanomas, adenocarcinomas, and squamous cell carcinomas have been developed
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for the study of differentiation (24).

More detailed discussions of in vitro

differentiation systems may be found in the following reviews by Schwartz and
Wiernik (25), Dexter and Spooncer (26), and Sachs (27).

The HL-60 cell line has proven to be a useful model with which to study
the phenomenon of and mechanisms involved in chemically-induced cellular
differentiation. Although a variety of agents have been demonstrated to induce the
maturation of these cells to more mature granulocyte-like, monocyte-like, or
macrophage-like elements, the mechanism(s) underlying these events is unclear.
This myriad of differentiation inducers, in addition to their diverse biological
effects, must, at some point, affect critical cellular processes which prompt cells
along an irreversible program toward differentiation.

The identification of such

processes will aid in the understanding of the phenomenon of differentiation and,
perhaps, enhance the ability to effect it.
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C ellular Biology of th e T ran sfe rrin Receptor.
Iron is an essential co-factor in diverse biological processes, including
electron transfer, oxygen transport, and catalytic reactions. Thus, the acquisition
and sequestration of iron is integral for cell viability at the prokaryotic and
eukaryotic levels. Transferrin, the major serum iron-binding glycoprotein present
at 0.4 g per 100 ml of blood in man, is requisite for cellular growth in vitro.
Accordingly, in virtually all serum-free media formulations, transferrin is an
obligatory component (28,29). Thus, transferrin may be considered a growth factor.
The transduction of growth modulatory signals from this ligand occurs via the
transferrin receptor (TfR), a dimeric glycoprotein of Mr 180,000 (reviewed in Refs.
30,31).
Structurally, TfR consists of identical subunits linked by a disulfide bond.
The bulk of the receptor exists extracellularly; trypsin treatment of whole cells
generates a 70 kD fragment which retains transferrin binding properties.

The

transmembranous and intracellular domains of this protein are 20 kD and 5 kD
in mass, respectively. The polypeptide chain of TfR differs from typical membrane
proteins in that it lacks a signal peptide leader sequence and it is oriented with
the N-terminus facing intracellularly. The receptor is post-translationally modified
with three N-asparagine-linked oligosaccharides, two of which are of the mannoserich type and the other being of the complex type (32). Heterogenous glycosylation
at these sites has been suggested as the reason for the characteristic appearance
of TfR as a doublet in certain cell lines on denaturing polyacrylamide gels (33).
Fatty acid acylation has been demonstrated on TfR, although the biological
implications of this event are unknown (34,35). The cytoplasmic portion of the
receptor contains serine residues which serve as substrates for phosphorylation by
protein kinase C and is thought to mediate receptor internalization.
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The cellular physiology of transferrin uptake via TfR (Fig. 1) displays unique
properties compared with other receptor-mediated endocytosis systems (36,37).
Receptor-mediated endocytosis usually results in the delivery of ligand or receptor
or both to the lysosomes for degradation; however, this is not the fate of
transferrin nor TfR.

At physiological pH, diferric transferrin bound to TfR is

internalized via a clathrin-coated pit mechanism at the cell surface. The receptorligand complex is routed to the endosomes, whereupon in the acidic mileau, iron
is released from transferrin for subsequent cellular storage. Apotransferrin, which
never dissociates from TfR during the internalization process, is finally delivered
back to the cell surface. At neutral pH, the apotransferrin has low affinity for its
receptor and is, therefore, released intact to the culture medium for repetitive
cycles of iron delivery.

R egulation o f T ran sferrin R eceptor a t th e P ro te in Level.
The regulation of TfR is complex with as many as three distinct conditions,
including iron status, cellular proliferation, and cellular differentiation, which
appear to modulate expression of receptor protein.

It is most obvious that TfR

expression can be modulated to maintain intracellular iron homeostasis; receptor
levels vary inversely with iron availability. When HeLa cells were incubated with
diferric transferrin or iron salts, a decrease was seen in TfR number, but not
binding affinity, as assessed by 12EI-Tf binding (38). Conversely, when K562 cells
were treated with desferrioxamine, an iron chelator, 12EI-Tf binding increased four
fold (39). This increase in TfR correlated with an increase in receptor biosynthesis
as measured by metabolic labelling with “S-methionine and immunoprecipitation
Finally, the subculturing of stationary phase cells at low density results in &
decrease in intracellular ferritin concentrations and an increase in TfR expression,
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F igure 1. Cellular metabolism of TfR. 1-3: TfR biosynthesis and secretion. 48: Receptor recycling. 4-9: The transferrin cycle. 4-6,10: Lysosomal pathway of
receptor-mediated endocytosis.

1: Biosynthesis of TfR in rough endoplasmic

reticulum. 2: Processing of TfR in the Golgi. 3: Insertion of TfR into the plasma
membrane. 4: Transferrin binding to its receptor in coated regions of the plasma
membrane.

5: Transfer to receptosomes or endosomes.

6: Acid-facilitated

dissociation of Fe*3, generating apotransferrin. 7: Transfer of transferrin and its
receptor to tubular elements of the trans Golgi. 8: Reinsertion of receptor into
the plasma membrane and dissociation of apotransferrin.

9: Iron loading of

transferrin. 10: Transferrin does not proceed to lysosomes during internalization.

(Reprinted with permission from Plenum Press.)
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suggesting that depletion of intracellular iron pools is a stimulus triggering TfR
biosynthesis (40).
The association between TfR and cell growth is extensive.

The original

reports of TfR demonstrated that receptor expression was correlated with cellular
proliferation in a variety of leukemia and solid tumor cells, as well as of normal
hematopoietic tissues. The first such evidence was obtained rather serendipitously.
Characterization of a newly isolated monoclonal antibody, B3/25, by Omary et al.
(41) in 1980 revealed that its antigen was a surface glycoprotein present on all
tested human hematopoeitic cell lines and was induced by mitogen stimulation of
peripheral blood lymphocytes. One year later, the antigen to B3/25 was positively
identified as the transferrin receptor (42).

These results were confirmed and

extended to include expression in solid tumor cell lines by another group using
the monoclonal antibody, OKT9, which was found to specifically immunoprecipitate
TfR (43). Trowbridge and Lopez (44) employed a different monoclonal antibody,
42/6, which, unlike B3/25, blocked binding of transferrin to its receptor, to inhibit
the growth in vitro of a human T-cell leukemia line. Surprisingly, this growth
inhibition could not be overcome by the addition of iron salts to the culture
medium, suggesting that the function of TfR may not be limited to iron uptake
alone.
The recent elucidation of the molecular details of T-lymphocyte activation
have further substantiated the role of TfR in cellular proliferation.

Mitogen

stimulation with phytohemagglutinin or phorbol esters induced sequentially the
appearance of receptors for interleukin 2 and transferrin before the onset of DNA
synthesis.

Interestingly, anti-TfR antibodies successfully blocked thymidine

incorporation, whereas antibodies to the interleukin 2 receptor were without
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inhibitory effect once TfR expression occurred. This implied that TfR induction is
a requisite event during lymphocyte activation (45).
The literature describing the relationship between TfR ana cellular
differentiation is equally extensive. Modulation of surface TfR activity has been
seen during cancer cell differentiation in a variety of model systems. Omary and
Trowbridge’s (41) original inadvertent examination of TfR described the virtual loss
of the B3/25 antigen on the surface of HL-60 cells upon induction of differentiation
with DMSO for two days. TfR down-regulation was quickly confirmed in HL-60
cells induced with RA (43). Moreover, this phenomenon was not limited to the
HL-60 line; other differentiation-indudble systems, including hemin-induced K562
cells (46) and dexamethasone-treated M l cells (47) showed similar results.

In

contrast to the above effects, Friend erythroleukemia cells express 3- and 6-fold
increases in cellular TfR after 3 and 5 days, respectively, of DMSO-induced
erythroid differentiation (48). This difference appears to be due to the increased
biochemical requirement for iron in the synthesis of hemoglobin in mature
reticulocytes. In addition, cellular enucleation serves as a distinct mechanism for
terminating replication in erythroid differentiation.

Thus, the increase in TfR

activity in Friend erythroleukemia cells is appears obligatory for the expresssion
of the mature phenotype.
Terminal differentiation, by definition, involves both the programmed
cessation of proliferation and the acquistion of the mature phenotype.

The

relationship between these two endpoints is ambiguous. Excepting for Friend cells,
which require increased iron uptake as part of its maturation program, TfR downregulation is a feature in all differentiating leukemic cell systems.

Since TfR

expression and cellular proliferation are positively correlated, it is unclear whether
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TfR down-regulation is more closely associated with differentiation per se or with
growth inhibition, which is a requisite part of the terminal differentiation process.
The mechanisms by which the various differentiation inducers modulate TfR
levels in HL-60 cells have been previously investigated for only two classes of
compounds, the phorbol esters and the anthracyclines. These agents modulate TfR
expression by altering two of the receptor’s aforementioned post-translational
modifications, phosphorylation and glycosylation, respectively. The anthracyclines,
aclacinomycin A (ACM) and marcellomycin, are potent inhibitors of N-linked
protein glycosylation (49). These agents have been implicated by our laboratory
in decreasing transferrin binding during differentiation by inhibiting the formation
of dolichol-linked oligosaccharide intermediates dining the biosynthesis of new
receptors (49). However, the evidence for this is indirect, since actual alterations
in the oligosaccharide chains of TfR molecules have not been demonstrated.
Using the phorbol ester, phorbol dibutyrate, May et al. (50) found a rapid
decline in 12SI-transferrin surface binding (t*=60 min) consistent with redistribution
of membrane-associated TfR to internal sites rather than a decrease in total
cellular TfR. Furthermore, this event was coincident with rapid phosphorylation
of the receptor which began within 5 min after treatment and reached a maximum
by 15 min of exposure to phorbol dibutyrate.

Subsequently, this group

demonstrated that TPA was approximately 30-fold more potent than phorbol
dibutyrate in stimulating receptor phosphorylation and internalization (51).
Phosphoamino acid analysis of maximally phosphorylated TfR ‘ licated that serine
was the only residue phosphorylated following phorbol ester treatment. In an in
vitro reconstitution system employing protein kinase C purified from rat brain, TfR
phosphorylation was achieved by the combined presence of Caa%phosphatidylserine,
and a phorbol ester. This provided confirmation that the effects of the phorbol
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esters could be mediated directly by protein kinase C-induced or catalyzed
phosphorylation of TfR. This synergism between intracellular Caa* and phorbol
esters, leading to TfR phosphorylation and down-regulation, was subsequently
demonstrated in intact HL-60 cells, further implicating the involvement of protein
kinase C (52). This mechanism for phorbol ester action was not limited to HL60 cells, but was demonstrated to occur in K562 cells (53).
Recently, this scheme for phorbol ester action has been challenged by three
groups.

The cloning of the human TfR (discussed below) has permitted the

application of molecular biological techniques to test the hypothesis of phorbol ester
action on TfR. Using oligonucleotide-directed mutagenesis, Kuhn et al. (54) created
mutant TfR cDNA expression vectors in which one of the five potential
phosphorylatable serine residues in the cytoplasmic domain of the protein was
changed to either threonine or alanine. Another mutant, containing a deletion of
the entire serine-rich region of 36 amino acids, was constructed. These were then
stably transfected into mouse Ltk' cells. Both wild-type and phosphorylation site
mutant receptors mediated transferrin internalization and iron uptake, in contrast
to the truncated TfR. The authors concluded that while the cytoplasmic domain
of TfR was essential for endocytosis, receptor phosphorylation was not a
requirement for internalization. However, definitive conclusions concerning the role
of phorbol ester-induced phosphorylation on TfR internalization were limited.
Although TPA induced wild-type TfR phosphorylation in this system, it failed to
promote receptor internalization of either endogenous murine TfR or transfected
human wild-type TfR in Ltk' cells.

This may reflect a fundamental difference

between the human leukemia and the mouse Ltk' cell lines.
Similar conclusions were obtained by a second group which replaced the
serine-24 residue, the putative site of TfR phosphorylation, with alanine and
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transfected this mutant expression vector into mouse 3T3 cells (55). Again, phorbol
esters failed to down-regulate endogenous or transfected TfR, even though induced
phosphorylation of wild-type transfectants was seen. The authors dted cell-specific
factors rather than sequence differences in the TfR molecules as a potential reason
for the differential effects between HL-60 and 3T3 cells. A final group transfected
a TfR expression vector containing the serine-24 residue mutagenized to a glycine
into CHO cells and reported no effect of TPA treatment on receptor recycling (56).
Although these data appear to contradict the model proposed by May et al.
(52), application of these results to the leukemia systems may not be appropriate.
In contrast with differentiating K562 or HL-60 cells, none of these cell lines
respond to phorbol esters with receptor down-regulation even when exam ining
endogenous TfR; the CHO line, in fact, increases surface TfR upon TPA exposure.
Because of these gross differences in cellular response, the involvement of a protein
kinase C-mediated phosphorylation of TfR in signalling receptor down-regulation
may still apply to the leukemia cells.

M olecular Biology o f the Transferrin Receptor.
Examination of the biosynthetic regulation of TfR has become possible with
the cloning of the human and murine variants of this protein. Ruddle et al. (57)
first described the molecular cloning of the human TfR by using the MOLT-4
human acute lymphoblastic T-cell leukemia as a source of DNA. They reported the
TfR gene to span 31 kb and to be organized into 19 exons. Subsequent study of
the cDNA clone, pCDTR-1, revealed an mRNA of 4.9 kb organized into a 2.8 kb
fragment at the 5’ end which codes for TfR protein and a 2.1 kb fragment at the
3’ end consisting of an untranslated sequence of unknown function (58). An open
reading frame of 2280 nucleotides specified a 760 amino acid polypeptide with a

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

16

calculated molecular weight of 84,910 daltons.

These data were confirmed by

Schneider et al. (59) who cloned the cDNA directly from MOLT-4 mRNA by using
immune-selected polysomes. The murine TfR was cloned from myeloma cell mRNA
and predicted an amino acid sequence sharing a high degree of homology with the
human protein (60).
The availability of TfR cDNA has permitted probing of receptor message
levels; hence, delineation of gene-level regulation for this system. The first such
report, however, occurred prior to the cloning of TfR and utilized the in vitro
translation of poly(A)* ENA and immunoprecipitation using polyclonal antibodies
to infer the relative abundance of TfR transcripts (39).

The iron chelator,

desferrioxamine, was found to increase TfR message by 3-fold in K562 cells after
an 8 h r incubation.

Using pCDTR-1 as a probe, Rao et al. (61) confirmed by

Northern blotting that desferrioxamine induced TfR mRNA and that hemin or
diferric transferrin lowered receptor transcripts. Moreover, by crude nuclear run
off assays, these changes appeared to result from transcriptional regulation.
The first demonstration that TfR message levels are altered during
differentiation was shown using monocytes isolated from whole blood. When these
cells were allowed to spontaneously mature to macrophages by culturing in vitro,
TfR transcripts increased dramatically from undetectable levels in the freshly
isolated monocytes (62). Biosynthetic regulation of TfR in a chemically-induced
differentiation system was first reported by our laboratory.

We showed that a

decrease in the steady-state level of receptor transcripts correlates with and
precedes a reduction in surface TfR in HL-60 cells induced along the granulocytic
pathway by DMSO (63). A similar phenomenon was found subsequently when HL60 cells were induced to differentiate by RA and ACM (64). While cells induced
with TPA did not appear to invoke biosynthetic regulation to effect a characteristic
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rapid down-regulation of surface receptors, dramatic reductions in TfR transcripts
apparently served to maintain low levels of receptor expression after 12 hours of
treatment. Using nuclear run-off and transcript half-life studies, Trowbridge et al.
(65) have subsequently demonstrated that the DMSO-induced decline in steadystate TfR mRNA levels is mediated at the transcriptional level. Nuclear run-off
assays in the monocytic differentiation of HL-60 cells by dibutryl cyclic AMP
revealed a decline in TfR transcription rates after 2 hours of inducer exposure (66).
It is already clear that TfR homeostasis is controlled at the gene level in
a complex manner replete with inducing and suppressing elements. These include
the intracellular iron concentration, the state of differentiation, and the phase of
cellular growth. Molecular dissection of the TfR gene and mRNA have revealed
multiple sites of positive and negative regulation. Kuhn et al. (67) first reported
that the site of iron regulation appeared to be post-transcriptional, based on studies
with transfected TfR cDNA’s possessing deletions in the 3’ untranslated region.
It should be recalled that the original cloning of TfR cDNA identified a large 2.1
kb untranslated segment of unknown function at the 3’ end of the message. This
report postulates that an interaction between an iron-dependent factor and specific
3’ sequences on the message may influence post-transcriptional events, such as
processing of precursor mRNA, transport, or mRNA degradation.

Recently, a

trans-acting factor, which bound TfR mRNA and conferred iron-dependent
regulation of TfR message stability, was identified using non-denaturing gel
electrophoresis (68). Further characterization of the 3’ region of the TfR message
identified the presence of five potential stem-loop structures as iron responsive
elements similar to one found in the mRNA for human ferritin (69).

When

chimeric transcripts containing these iron responsive elements cloned into the
human growth hormone gene were transfected into murine cells in transient
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expression assays, the production of growth hormone became iron responsive.
These 3’ elements on the TfR mRNA appeared to confer iron-regulated transcript
stability, as the half-life of the message was 20-fold greater in the presence of
desferrioxamine than under control conditions (70).
Conventionally, gene regulation is ascribed to the 5’ region of DNA, the site
of regulatory protein binding to promoter or repressor elements.

A 365 bp

fragment from the 5’ upstream region of the TfR gene was isolated by Ruddle et
al. (71). Sequence analysis revealed a TATA box, a consensus Spl recognition site,
and a highly GC-rich region that consisted largely of four repeats of the sequence
GGGGC, arranged as one inverted copy followed by 3 direct repeats. This motif
was reminiscent of the promoter regions for the human dihydrofolate reductase and
the murine interleukin 3 genes. This TfR promoter region also possessed ironresponsive properties.

When a large 1.6 kb 5’ fragment of the TfR gene was

subcloned upstream to the structural gene for chloramphenicol acetyltransferase,
reporter gene mRNA levels were 3-fold higher when transfected cells were treated
with desferrioxamine than after treament with hemin (72).

Thus, TfR levels

appear to be determined predominantly by the concentration of TfR message, with
the regulatory regions for this gene composed of basal and inducible elements on
both non-coding DNA sequences and untranslated mRNA. Such regulation has
been intensively studied with the metallothionein gene, where the basal and
inducible elements have been shown to operate in an independent fashion (73).
Such regulation would presumably allow cells exquisite control over surface TfR
activity, a function clearly critical to cellular metabolism, growth, and
differentiation.
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Expression of the TfR is critical to maintain many critical cellular processes,
including intracellular iron homeostasis,

proliferation, and

differentiation.

Investigations of the regulatory components for this receptor system have yielded
a wide assortment of potential mechanisms consistent with the role of TfR in a
variety of pivotal cellular events. Transcription of the TfR gene may be modulated
by protein:BNA interactions at various promoter sites. Message levels may further
be altered by protein :RNA interactions at the 3’ untranslated region of the mRNA.
Surface receptor levels may be affected by protein kinase C activity via
phosphorylation and subsequent internalization of TfR.

Finally, the receptor’s

interaction with its ligand may be a function of its appropriate glycosylation during
biosynthesis. The mechanism(s) which applies to the TfR modulation seen during
the induction of leukemia cell differentiation requires precise definition.

In

addition, the delineation of etiological nature for this event may, perhaps, establish
the true role of TfR activity during differentiation. Investigations of this nature
require different tools than the commonly employed differentiation inducers which,
in addition to modulating TfR expression, have a host of pleiotropic effects on cells.
Antisense oligodeoxynucleotides may represent a suitable class of compounds with
which to undertake these studies. By appropriate selection of target sequences, it
is, in theory, possible to inhibit the expression of a single gene within a cell. Any
such sequelae resulting from this could then be ascribed to the function of that
single gene product.
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O ligodeoxynucleotides.
The exploitation of synthetic DNA as a specific inhibitor of gene expression
is relatively new. However, the concepts behind this approach was first proposed
by Grineva et al. as early as 1967 (156,157). The pioneering work of Zamecnik
and Stephenson (74,75) in 1978 first described the inhibition of Rous sacoma virus
replication by oligonucleotides. In the following decade, this strategy was applied
in a variety of viral and eukaryotic systems against many different cellular targets.
In addition, the emergence of novel synthetic methods to modify the chemistry of
oligonucleotides has permitted the continued development of more potent structural
analogues of DNA. This field has only recently matured past the phenomenological
stage to one in which critical investigations into the mechanism of antisense action
within the cell are now being pursued. Recent studies of the pharmacokinetics and
metabolism of oligonucleotides in in vivo models are, perhaps, harbingers of its
potential role as a new class of chemotherapeutic agents.

These exciting

developments have been the topic of recent reviews (76,77,78,79).
The antisense DNA field can trace its roots to the discovery of RNA
sequences which serve as endogenous biological inhibitors in prokaryotes and
eukaryotes. This was first demonstrated for the osmoregulatory protein, OmpF,
of E. coli (80).

A novel species of RNA, termed micRNA (mRNA-interfering

complementary RNA), was found to inhibit the translation of OmpF transcripts by
hybridizing with it, resulting in premature termination of transcription of the
OmpF gene or destabilization of OmpF mRNA. A eukaryotic analogue to micRNA,
termed tcRNA102 (translational control RNA), was found to specifically inhibit
translation of the chicken myosin heavy chain in vitro (81). Sequence analysis of
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this 102 bp molecule revealed segments complementary to the 5’ terminal part of
the chicken myosin heavy chain mRNA.
This apparently endogenous strategy of gene regulation was pursued through
the then newly developed methods of gene transfection into eukaryotic cells.
Microinjection or calcium phosphate precipitation techniques permitted the
introduction of foreign DNA into host cells where, after stable integration into the
genome, expression of the gene product could be demonstrated.

Rather than

promoting the synthesis of a particular foreign protein, however, the expression of
an endogenous gene could be inhibited if the transfected cDNA were inserted in
a reversed orientation behind a promoter sequence. The antisense, rather than
the sense, strand would then serve as a template for synthesis of an mRNA which
would then be complementary to the coding transcript for the gene of interest.
The RNA duplex thus formed would then hinder sense strand translation by
mechanisms similar to those postulated for micRNA and tcRNA102.
This particular strategy, termed antisense RNA, was applied to a variety
of eukaryotic targets.

In 1984, Izant and Weintraub (82,83) constructed an

antisense plasmid to the herpes simplex virus thymidine kinase (TK) gene behind
either constituitive or inducible viral promoters. These were then co-microinjected
with the normal sense herpes TK plasmid into TIC0 mouse L-cells and the induced
TK activity was assessed by thymidine incorporation.

Antisense transcripts

complementary to as little as 52 bp of the TK gene inhibited thymidine
incorporation, whereas the transfection of control plasmids were without effect.
The sequence specificity of this process was shown by a lack of enzyme inhibition
seen when the non-cross hybridizing chicken TK gene and the viral TK antisense
construct were co-microinjected. In addition, suppression of endogenous actin gene
activity by antisense RNA to actin was manifested by a reduction in actin
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microfilament cables by immunofluorescence and by a decreased growth rate. The
authors concluded by stating that, "antisense RNA may be generally useful for
suppressing the expression of specific genes in vivo and may be a potential
molecular alternative to classical genetic analysis."
Indeed, the antisense RNA approach was quickly applied to one of the
principle models of gene expression, fi-globin. Melton (84) showed RNA duplex
formation and translational inhibition by pre-injecting antisense RNA into frog
oocytes before the introduction of B-globin mRNA.

Deletion mapping indicated

that the aritisense molecules must hybridize to the 5’ end of the B-globin transcript
in order to efficiently inhibit translation.

The importance of antisense duplex

formation at the 5’ end of targetted mRNA was also noted by Izant and Weintraub
(83) in their studies of TK gene inhibition.
The rapid down-regulation of the c-myc oncogene is a well-described
phenomenom seen during the chemically-induced differentiation of HL-60 cells (85).
Although increased myc expression is generally seen in rapidly proliferating cells,
gene transfer experiments have shown that the constituitive expression of c-myc
inhibits the induction of differentiation in erythroleukemia cells (86,87). When HL60 cells were stably transfected with an antisense construct to the myc oncogene,
suppression of endogenous myc gene expression by antisense RNA, decreased cell
proliferation, and the triggering of monocytic differentiation were seen (88). It was
concluded that c-myc had a functional role in leukemia cell differentiation.
However, like that of the transferrin receptor, the involvement of c-myc downregulation in differentiation per se versus the cessation of proliferation which
accompanies terminal differentiation is difficult to dissect.
Antisense RNA, while successful in vitro as a specific suppressor of gene
activity, has inherent handicaps which may prevent its viability as a therapeutic
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modality. The delivery of large expression vector plasmids into mammalian cells
requires

laborious

techniques

such

as

calcium

phosphate

precipitation,

microinjection, or electroporation. Since these methods are generally performed ex
vivo on single cell suspensions, the number and types of cells amenable to these
manipulations are severely limited. The incorporation of the DNA into the host
genome cannot, at present, be directed in a controlled manner.

Without this

capability, the possibility remains that the random integration of foreign DNA may
disrupt functions of the host genome that lead to deleterious effects. Finally, it is
difficult to control the level of expression of these plasmids once inside cells.
Vector expression can be grossly modulated by employing inducible promoters, for
example, the metallothionein promoter which responds to cadmium or the mouse
mammary tumor virus promoter which responds to dexamethasone. However, the
fine control over antisense RNA expression, already difficult to achieve in vitro,
but presumably necessary for use in humans, is likely to be even more complex in
an in vivo setting where host factors may interfere.
considerations

served

as

stimuli

for

the

All of these practical

development

of

synthetic

oligodeoxynucleotides as antisense inhibitors of gene expression.

Phosphodiester O ligodeoxynucleotides as A ntisense Inhibitors.
The advent of commercially available DNA synthesizers and improved
methodologies for synthesizing DNA (reviewed in

Ref.

89) ushered in

oligodeoxynucleotides as viable alternatives to antisense RNA. As late as 1977,
it was concluded that the synthesis of yeast alanine tRNA by conventional
enzymatic and chemical means would require 20 man-years of effort (90). Today,
DNA synthesizers can easily produce overnight an oligodeoxynudeotide 2 to 3 times
the length of a tRNA molecule.

Although there remains a daunting array of
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obstacles to overcome before these agents may be used therapeutically,
oligodeoxynucleotides possess many attractive advantages as anti sense inhibitors.
Statistically, a sequence of 17 bp should be found only once in the entire
human genome and considerably shorter sequences, i.e., 12-mers, may in principle
be used to target mRNA since only the transcribed fraction of DNA must be
considered.

The production of these short sequences by conventional. DNA

synthesizers is trivial, although synthesis of pharmaceutical amounts of purified
DNA remains economically unfeasible. Furthermore, short sequences, as opposed
to multi-kilobase long plasmids, easily enter cells without the need for
extracorporeal manipulations, such as microinjection.

The synthesis of these

compounds by automated means permits virtually any gene, whose sequence is
known, to be targetted. Lastly, newly developed synthetic analogues which may
increase the potency or efficacy of antisense molecules may be rapidly assessed in
in vitro systems.
The innovative studies by Zamecnik and Stephenson (74,75) of antisense
oligodeoxynucleotides in mammalian cell transformation by Rous sarcoma virus
(RSV) were the earliest demonstrations of sequence specific inhibition by synthetic
DNA. A tridecamer (13-mer) complementary to terminal repeat sequences of viral
35S RNA was found to inhibit viral replication in chick embryo fibroblast cultures
infected with RSV. This was assessed by measuring reverse transcriptase activity
released into the culture medium by infected cells.

Moreover, in cell-free

translation systems, it was determined that this tridecamer inhibited the
translation of viral RNA in a sequence and concentration dependent manner.
The early work in this field by Zamecnick and others established some of
the basic tenets of antisense oligodeoxynucleotides as potential therapeutic agents.
Ideally, these compounds must fulfill criteria concerning selectivity of action,
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molecular stability, and solubility. Obviously, in order to minimize toxicity, any
chemotherapeutic

agent

must

specifically interact

with

its

target

site.

Oligodeoxynucleotides interact with target DNA or RNA by Watson-Crick base
pairing rules. Hence, subtle alterations to the linear base sequence of antisense
molecules should, in theory, dramatically affect their hybridization potential and,
therefore, their biological efficacy.

Since a variety of nucleases, which exist

intracellularly and in sera, can degrade oligodeoxynucleotides, antisense molecules
must be sufficiently stable to enzymatic hydrolysis in order to reach their targets
at effective concentrations. Finally, these compounds must be water-soluble, yet
be able to pass through the cell membrane. The polyanionic character of normal
phosphodiester oligodeoxynucleotides may impede transport through the cell
membrane.

Conversely, a compound that is too lipophilic may have limited

practical potential because of its reduced aqueous solubility. As will be discussed
later, recent synthetic modifications to the basic chemistry of DNA structure have
permitted the development of analogues which have improved the ability of
oligonucleotides to better satisfy the above criteria.
The early studies with antisense DNA were limited to first generation
oligodeoxynucleotides with intemucleoside phosphodiester linkages similar to that
of native DNA. The HL-60 cell line has served as a convenient model system for
many of the early antisense studies.

Wickstrom et al. (91) employed a

pentadecamer (15-mer) complementary to the initiation codon region of the c-myc
oncogene. When HL-60 cells were incubated with oligodeoxynucleotides at 10 uM,
a reduction in myc protein was observed by immunofluorescence and by
radioimmunoprecipitation. Furthermore, cell proliferation was inhibited in a dosedependent manner. Experiments using antisense pentadecamers to the vesicular
stomatitis virus (VSV) or to the human immunodeficiency virus (HIV) tat gene as
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negative controls were without effect. Using the same system, Holt et al. (92)
demonstrated similar results, hut, in addition, found that the anti-myc
oligodeoxynucleotide weakly induced granulocytic differentiation. Maturation was
assessed by morphology and NBT staining, with approximately 30% of cells
evidencing NBT positivity after 3 days of treatment.

These results, however,

contrasted with the previously described studies of antisense RNA to myc which
resulted in monocytic differentiation (88).
To further address the role of c-myc protein function, the same anti-myc
pentadecamer was used to study the mitogen-induced activation of lymphocytes.
The c-myc gene is normally silent in resting lymphocytes, but is activated upon
mitogen stimulation.

Both c-myc protein expression, quantitated by Western

blotting and immunoprecipitation, and entry into S phase, assessed by propidium
iodide staining, were completely inhibited by 30 uM of antisense DNA in PHAstimulated lymphocytes (93). An antisense molecule to VSV was without effect.
Interestingly, the anti-myc oligodeoxynucleotide did not prevent the induction of
TfR, interleukin 2 receptors, and sH-uridine incorporation into mitogen-stimulated
cells.

Since these phenomena are part of the G0 to G, transition following

lymphocyte activation, c-myc expression appeared critical for S phase entry or
traversal. However, TfR and interleukin 2 receptor expression were apparently
insufficient to support DNA synthesis in the absence of normally induced levels of
c-myc protein.

These results were verified for interleukin 2 stimulation of T

lymphocytes (94).
Antisense inhibition by phosphodiester oligodeoxynucleotides has been
demonstrated for a variety of other eukaryotic proteins. An octadecamer (18-mer)
to the c-myb oncogene interfered with the normal hematopoiesis of human bone
marrow mononuclear cells at a concentration of 14 uM (95). This same molecule
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displayed sequence-specific growth inhibition of human myeloid leukemia cell lines,
including HL-60, however, no differentiative effects were noted (96). Finally, the
anti-myft DNA acted similarly to the anti-myc oligomer in preventing S phase entry
in the mitogen-stimulated lymphocyte model (97). DNA synthesis and mitosis were
suppressed in exponentially growing Balb/c3T3 cells exposed to 30 uM of antisense
oligodeoxynucleotides to cyclin, otherwise known as the proliferating cell nuclear
antigen (98).

Antisense DNA against the dihydrofolate reductase gene caused

specific translational arrest in a rabbit reticulocyte lysate system (99).
O ligodeoxynucleotide Analogues a s A ntisense Inhibitors.
Although the normal phosphodiester oligodeoxynucleotides have been used
with success as antisense inhibitors in tissue culture systems, their inherent
susceptibility to enzymatic hydrolysis by nucleases severely limits their utility in
vivo and, sometimes, in vitro.

This is a rapid process.

In HeLa cell

postmitochondrial cytoplasmic extracts, a half-life of 30 min was observed for
oligodeoxynucleotide degradation (100). In undiluted bovine calf serum, degradation
of the 5* end-labelled DNA appeared complete within 15 min. These data may be
overestimates since a delineation was not made between intemucleoside bond
hydrolysis and 59 phosphatase removal of the radiolabel in these studies.
In addition, the polyanionic character of the phosphodiester bonds may
impede passage of antisense molecules through cell membranes. Theoretically, a
reduction in the charge density of the intemucleoside bonds may improve cellular
deliver of antisense molecules.

For these reasons, and to improve efficacy,

attempts have been made to structurally modify synthetic DNA without
significantly affecting the hybridization potential. Most attention has focused on
the intemucleoside linkages, although the base and ribose moieties are also
potential sites for modification (Fig. 2a).
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F igure 2 a.

Intemucleoside chemistry of synthetic oligonucleotides.

A

representative intemucleoside bond in a synthetic oligonucleotide is shown. Base
is adenine, guanine, cytosine, or thymidine. Substituents to the intemucleoside
phosphate may appear at the X and Y positions, with both occupied by oxygen
atoms in normal, unmodified oligonucleotides. The common terminology for the
variously substituted DNA analogues are shown.
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The methylphosphonates were among the first candidate DNA analogues
investigated.

Miller and Ts’o (101) first developed these nonionic nucleic acid

analogues which contain a 3’-5’ methylphosphonate group in place of the negatively
charged phosphodiester group. These compounds were shown to be resistant to
nuclease hydrolysis and to penetrate mammalian cells in culture (102). Although
these analogues have been vigorously pursued as anti-viral agents in a variety of
systems, they suffer from their own inherent disadvantages which may preclude
their eventual utility. The synthesis of methylphosphonates is not stereospecific,
therefore, a chiral center will be generated about each methylphosphonate linkage.
An oligomer of base length n will have 2(n'1) diastereoisomers.

It is unknown if

correct hybridization with mRNA is abrogated by chirality at the intemucleoside
bond. They are relatively insoluble in aqueous media; in fact, methylphosphonates
without polar terminal phosphate or phosphodiester groups and longer than 12mers are virtually insoluble (103). Because of this enhanced lipophilicity, these
molecules may selectively partition within cellular membrane structures, thereby
limiting their free concentration.

All of these factors may contribute to the

necessity of using high concentrations (typically 100-300 uM) in order to achieve
appreciable antisense activity.
A second class of oligodeoxynucleotide analogues are the phosphorothioates.
Here, one of the nonbridging oxygen atoms in each intemucleoside phosphate
linkage is replaced by a sulfur atom, thus providing several theoretical advantages.
This reduces the anionic charge density at each intemucleoside bond and,
therefore, of the entire molecule; hence, cellular uptake may be improved. These
compounds retain aqueous solubility since this substitution does not confer the
extreme lipophilicity seen with the methylphosphonates.

This substitution also

provides resistance to enzymatic hydrolysis as the phosphorothioate linkage is not
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a good substrate for serum and cellular nucleases. Finally, the synthesis of these
analogues from deoxynucleoside hydrogen phosphonate precursors is relatively
simple and easily adapted to conventional automated synthesizers (104). lik e the
methylphosphonates, however, phosphorothioates contain chiral phosphorus centers
which create multiple diastereomers.
The

actual

physicochemical

properties

of

the

phosphorothioate

oligodeoxynucleotides have been meticulously investigated by Stein et al. (105).
The nuclease susceptibility of these compounds was tested against a variety of
DNases.

By comparing oligomer half-lives during digestion, phosphorothioate

analogues were found to be approximately 20-fold more stable to the endonuclease
Sj and to the exo- and endonuclease Pi than their phosphodiester counterparts.
Against snake venom phosphodiesterase, the phosphorothioates were virtually
invulnerable with half-lives over 1000 times greater than the corresponding
phosphodiesters. As will be discussed below, one potential mechanism for antisense
DNA activity is hybridization to mRNA, thereby creating a mixed RNA:DNA
hybrid. This complex serves as a substrate for RNase H which cleaves only the
RNA strand of the heteroduplex; hence, the mRNA target of an antisense molecule
will be selectively hydrolyzed.

In these studies, duplexes consisting of a

homopolymer of deoxythymidine hybridized to oligoadenylic acid were digested with
RNase H.

This reaction occurred approximately 20 times faster with a

phosphorothioate homopolymer than with a phosphodiester homopolymer.
That RNase H activity is greater with the phosphorothioates may underlie
their enhanced biological efficacy over the conventional phosphodiester oligomers.
In

a

direct

comparison

of

antisense

activity,

normal

phosphodiester

oligodeoxynucleotides were compared with their corresponding analogues in the
phosphorothioate, methylphosphonate, and phosphotriester series (106). Similar
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sequences, directed against the initiation codon region of the chloramphenicol
acetyl transferase gene (CAT), were tested for their ability to inhibit the expression
of plasmid-directed CAT activity in CV-I cells. At 30 uM, the phosphorothioate
analogues were most efficacious, followed by the methylphosphonate and triester
analogues; the least activity was shown by the normal phosphodiester compounds.
This was evident despite the fact that the hybridization potential, as reflected by
duplex melting temperatures, for the phosphorothioates are reduced by 15-20°C
relative to the corresponding phosphodiester sequences (105).

Thus, although

phosphorothioates do not form heteroduplexes with mRNA as readily as their
phosphodiester counterparts, they may be more biologically active as antisense
molecules due to their resistance to DNase degradation and their promotion of
RNase H scission activity.
Although a variety of other synthetic analogues exist, these have been
applied to fewer biological systems.
intemucleoside

linkages

to

create

These include modifications of the
phosphorami date,

phosphotriester,

or

phosphorodithioate groups. The recently described phosphorodithioates have all of
the previously mentioned advantages of the phosphorthioates. However, the fact
that both nonbridging oxygen atoms of the intemucleoside bonds have been
replaced by sulfur results in retention of achirality about the phosphorus atom.
The theoretical problems imposed by the 2<nl) diastereoisomers formed, therefore,
would be eliminated.
Another class of oligodeoxynucleotides are the a-analogues in which the Banomeric linkage formed by the dexoyribose moiety with the purine or pyrimidine
base in native DNA is transposed into the unnatural a linkage. This modification
renders these molecules nuclease resistant.

Interestingly, the a-analogues form

parallel rather than antiparallel duplexes with native J3-DNA or RNA.
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Unfortunately, duplexes formed by a-DNA:mRNA hybridization are poor substrates
for RNase H (107). In addition, cost is a significant problem at present for these
compounds; cc-anomeric nucleoside precursors cost as much as 30 times that of
their £ counterparts (103). Lastly, oligodeoxynucleotides may be modified by the
covalent attachment of conjugates to increase their biological activity. Nucleic acid
intercalators, such as acridine, may be conjuated to oligomers to stabilize
hybridization interactions with DNA or RNA (108,109). The conjugation of an ironEDTA group provides cleavage activity to oligomer in the form of reactive oxygen
radicals generated in the vicinity of the duplex (110). The attachment of a 1,10o-phenanthroline copper group to oligomers also imparts cleavage activity by
similar mechanisms (111). The oxygen radicals generated are so potent, however,
that these compounds are degraded by autocatalysis.

A ntisense DNA Analogues as Antiviral Agents.
While conventional phosphodiester oligomers have been exploited extensively
to suppress oncogene expression in eukaryotic cells, the antisense analogue
compounds have proven to be extremely active as inhibitors of viral replication,
especially that of the human immunodeficiency virus (HIV).

Eight years after

publishing their landmark studies on the suppression of RSV replication (74,75),
Zamecnik and coworkers (112) investigated the ability of unmodified phosphodiester
antisense oligodeoxynucleotides to inhibit HIV. At 50 uM, a 20-mer complementary
to the HIV splice acceptor site inhibited viral replication, as assessed by reverse
transcriptase activity, and gene expression, as determined by the production of
virus-encoded pl5 and p24 proteins. Additional antisense oligomers targetted to
other regions of the viral genome proved less inhibitory in these assays.

In

expanded studies, this group showed that antisense 20-mers against the cap site,
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5’ untranslated region, and poly(A) signal of HIV RNA were most effective at
inhibiting syncitia formation and p24 elaboration in virally infected cells (113).
These sequences are related geographically and are found within the repeated
sequence at the ends of retroviral RNA.
The methylphosphonate analogues were initially assessed in non-HIV viral
systems. Miller and Ts’o (114) reported that a methylphosphonate octamer against
the splice acceptor site of herpes simplex virus (HSV) type 1 showed antiviral
activity by a variety of measures, including actual virus titers and viral DNA and
protein synthesis. When a vesicular stomatitis virus model was tested, the same
group determined that these analogues specifically inhibited viral protein synthesis
in an in vitro translation system and viral replication during the infection of mouse
cells (115). Unfortunately, due to the aforementioned disadvantages with these
analogues, the concentrations of oligomers used in these experiments was high
(100-300 uM). Zamecnik’s group (116) showed that these analogues, at only 20
uM, could be exploited to inhibit HIV. The reason(s) for the striking difference
in the effective concentrations between this and the previous studies was not
addressed.
By far, the phosphorothioate analogues have proven to be the most
intriguing and efficacious anti-HIV oligomers. A number of interesting observations
were reported by Matsukura et al. (117) in the first investigation of
phosphorothioates in the HIV system. First, phosphorothioate inhibition of HIV
activity was dependent on length, with 28-mers being more potent than 14-mers;
5-mers showed no activity. Surprisingly, the antiviral activity of these compounds
was not sequence-specific. In fact, the most potent antiviral activity was shown
by a 28-mer phosphorothioate oligodeoxycytidine homooligomer (S-dCas) rather than
antisense

molecules complementary

to

HIV sequences.

The

antisense
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phosphorothioates were active, but at higher concentrations (10-25 uM). As little
as 5 uM of S-dCjg completely inhibited the cytopathic effect of HIV on de novo
infected T-cells without being cytotoxic for non-infected cells. Furthermore, while
S-dCM inhibited the de novo synthesis of HIV DNA in newly infected cells down
to 1 uM, it failed to inhibit gag protein synthesis in chronically infected cells at
concentrations up to 25 uM. This suggested that the phosphorothioate analogues
may be effective antiviral agents by mechanisms independent of antisense means.
The authors concluded that the antiviral activity of S-dC^ was mediated by
inhibition of HIV proviral DNA synthesis, possibly by direct interference with the
retroviral reverse transcriptase. This scheme, involving direct interference of a
DNA modifying enzyme by the phosphorothioate homooligomer, was supported by
work from another group showing that S-dCjg was a competitive inhibitor of the
HSV type 2 DNA polymerase, but interfered with human DNA polymerases less
effectively (118).
Sequence-specific

antisense

suppression

of

HIV

expression

by

phosphorothioates was eventually demonstrated by Matsukura et al. (119) in a
follow-up report.

A phosphorothioate 28-mer (S-arev), complementary to the

initiation sequence of HIV-1 rev, selectively inhibited the expression of a retroviral
protein, p24 gag, in T-cells chronically infected by HIV. This process was dosedependent through 25 uM of S-ocrev, which inhibited viral protein production by
90% without significant toxicity. Antiviral activity was also assessed by Northern
blotting; S-arev treatment of infected cells resulted in a disappearance of the 9.2
kb genomic mRNA of HIV. The sequence specificity of this inhibition was shown
when equivalent doses of S-dC^, an unmodified phosphodiester antisense oligomer
to rev, and a random sequence phosphorothioate molecule with the same base
composition as S-arev proved ineffectual. The increased activity against HIV by
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the

phosphorothioate analogues over identical sequences in

phosphodiester series was confirmed independently (120).

the

normal

Furthermore, viral

inhibition by these antisense compounds was not a universal phenomenon as a
phosphorothioate antisense oligomer to the HIV gag gene did not alter the mRNA
profile of viral

expression.

Taken

together, these

data

suggest that

phosphorothioate oligodeoxynucleotides may exert antiviral effects by two distinct
mechanisms. The homooligomers, i.e., S-dCjg, may selectively inhibit the function
of retroviral reverse transcriptase, while antisense molecules, i.e., S -a re v , may act
more classically to promote translation arrest of targetted viral mRNA.

These

targets, however, must be appropriately selected as implied by the experiments
with the anti-gag oligomer.

M echanism s o f A ntisense O ligodeoxynucleotide Inhibition o f Gene A ctivity.
Only recently has the molecular mechanism(s) of antisense activity been
systematically investigated. Conventionally, there are two postulated mechanisms
by which antisense oligomers may induce hybridization arrest of translation (Fig.
2b).

The formation of an RNArDNA duplex may exert a direct steric effect,

blocking the binding of factors required for the initiation of translation or impeding
translocation of the ribosome along the mRNA resulting in chain termination.
Alternatively, the mRNA may be cleaved by RNase H at the site of the RNA:DNA
heteroduplex.

RNase H, a ubiquitous enzyme required for DNA replication, is

thought to digest the short RNA primers used to initiate DNA synthesis. Walder
and Walder (121) have shown that in freshly preparated reticulocyte lysates, which
contain only 1-2% of the level of RNase H in nucleated cells, nearly 100% of
targetted mouse a- or B-globin mRNAs were digested at the site of hybridization
with a complementary phosphodiester oligodeoxynucleotide within 1 hour under

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

37

F igure 2 b. Potential mechanisms for antisense mediated gene inhibition.
Above. The typical pathway of protein synthesis is shown. DNA is transcribed
into mRNA containing a poly-A4 tail onto which ribosomes bind thereby initiating
the synthesis of the encoded protein.
Middle.

The hybridization of a complementary antisense oligonucleotide to its

target sequence on single-stranded mRNA can mediate inhibition of gene expression
through one of two mechanisms. In hybridization arrest, the resultant DNA:RNA
heteroduplex prevents the binding of elements involved in protein synthesis. These
may include, but are not limited to, the ribosomes. Alternatively, this DNA:RNA
heteroduplex is a substrate for RNase H which specifically digests the RNA strand.
The truncated mRNA does not serve as a normal substrate for the binding of the
protein synthetic machinery.
Bottom. The hybridization of a synthetic oligonucleotide to double-stranded DNA
results in the formation of a DNA triplex.

This structure may prevent the

recognition or binding of transcriptional elements thereby inhibiting gene
expression.
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conditions of active translation.

Poly(rA)*oligo(dT), a competitive inhibitor of

RNase H, abolished the translational inhibition effected by the antisense oligomers.
This indicated that the formation of a RNA:DNA heteroduplex alone was
insufficient to inhibit protein synthesis; cleavage of the mRNA by RNase H is
requisite to achieve translational arrest.
An unconventional, yet potentially exciting, mechanism of antisense gene
inhibition involves targetting duplex DNA rather than single-stranded mRNA. This
idea has conceptual advantages and disadvantages compared to the conventional
approaches

described

above.

Whereas

multiple

copies

of

antisense

oligodeoxynucleotides would be required intracellularly to hybridize to the numerous
copies of mRNA, which are themselves turning over constantly, theoretically, only
one antisense molecule is necessary to inhibit gene expression at the DNA level.
A potential limitation to this approach, oligomer transport through the complex
nuclear membrane to the chromosomes, has been recently demonstrated.

The

primary drawback is that, unlike duplex formation where the well-characterized
Watson-Crick

base

pairing

scheme

applies,

our

understanding

of the

physicochemical rules for triplex formation is extremely limited and controversial.
Using oligodeoxynucleotides, one report provided NMR evidence of triplex DNA in
which one homopurine and one homopyrimidine strand are Watson-Crick base
paired, and another homopyrimidine strand is Hoogsteen base paired parallel to
the purine strand along the major groove (122).

Others have evidence for a

purine-rich oligomer binding in a parallel orientation along the major groove to the
purine-rich strand of a double helix (123).
In spite of these difficulties, antisense inhibition by putative triplex DNA
formation has been demonstrated in two systems.

Cooney et al. (123) first

synthesized a purine-rich 27-mer designed to bind duplex DNA at a single site

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

40
within the 5’ end of the human c-myc gene, 115 bp upstream from the origin of
transcription. This oligomer inhibited c-myc transcription in vitro and was found
to form a DNA triplex, as assessed by gel mobility shift and DNase footprinting
assays.

Maher

oligodeoxynucleotide

and

co-workers

(124)

which blocked the

described

recognition

a

of a

metallothionein promoter by various DNA binding proteins.

pyrimidine-rich
double

helical

The inhibition of

binding by the prokaryotic modifying enzymes, Ava I restriction endonuclease and
Taq I methylase, and by the eukaryotic transcriptional factor, Spl, to the
homopurine target site was sequence-specific.

The development of oligodeoxynucleotides as antisense molecules represents
a logical extension of the original discoveries of endogenous RNA molecules as
regulators of gene expression in prokaryotes and eukaryotes.

The advent of

commercially available DNA synthesizers and simplified chemical methodologies for
DNA production was a crucial catalyst in accelerating the progress of this field.
Where oligodeoxynucleotides were once oddities limited to synthetic chemists, these
technologies have provided abundant supplies of a nearly infinite selection of
antisense sequences to cell and molecular biologists for the study of and
intervention of gene expression.

In less than a decade, second generation

analogues which address many of the inherent limitations of the native
phosphodiester series have been developed and confirmed to be more efficacious.
Although experience with these compounds has been, for the most part, limited to
in vitro settings, antisense oligodeoxynucleotides are currently being investigated
in animal models for their pharmacokinetics and metabolism in vivo. With the
potential of clinical trials on the horizon, the application of antisense
oligodeoxynucleotides and their analogues as specific inhibitors of gene expression
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in the treatment of disease is distinctly possible. The continued study of these
compounds in a variety of systems may expedite that possibility.
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MATERIALS AND METHODS

Chemicals and Cells.
DMSO, TPA, RA, NBT, a-naphthyl acetate, aprotinin, insulin-transferrinselenium, bovine serum albumin, gentamycin, penicillin/streptomycin, propidium
iodide, ribonuclease type I-A, dibutyl phthalate, dinonyl phthalate, and pre-stained
protein molecular weight markers were purchased from Sigma Chemical Co. (St.
Louis, MO). SB(#21,329-2), carbon disulfide (#27,0660-0), pyridine (#27,097-0), and
triethylamine (#23,962-3) were obtained from Aldrich Chemicals (Milwaukee, WI).
ACM was a gift from Bristol-Myers Co. (Wallingford, CT). FITC-conjugated and
unconjugated anti-human transferrin receptor monoclonal antibody was purchased
from Becton-Bickenson Inc. (Mountain View, CA). Paraformaldehyde and XRP-5
X-Omat film were supplied by Eastman Kodak Co. (Rochester, NY). Nonidet P40 was obtained from US Biochemical Corp. (Cleveland, OH).

Guanidinium

thiocyanate was purchased from Fluka Chemical Corp. (Hauppauge, NY).
Oligonucleotide sizing markers were obtained from Pharmacia LKB (Piscataway,
NJ).

Enzymobead radioiodination reagent and 96-well dot blot manifold were

supplied by Bio-rad Laboratories (Richmond, CA). Na125I (carrier-free, 3.7 GBq/ml)
and Rainbow molecular weight markers were supplied by Amersham (Arlington
Heights, IL).

{^PjdCTP (>3000 Ci/mmol), l^Pjgamma-ATP (>3000 Ci/mmol),

[“ SJmethionine (>800 Ci/mmol), En*Hance, and Gene Screen hybridization filters
were purchased from New England Nuclear Corp. (Boston, MA). Human HL-60
promyelocytic leukemia cells, a gift of Dr. Robert C. Gallo of the National Cancer
Institute, were passaged in RPMI 1640 culture medium (Grand Island Biological
Co., Grand Island, NY) supplemented with 15% fetal bovine serum (Grand Island
Biological Co.) and penicillin/streptomycin (Grand Island Biological Co.) in a
42
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humidified atmosphere of 95% air/5% C02. In some experiments, a sub-clone of
HL-60 cells adapted to growth in serum-free culture medium was employed. These
cells, a gift of Dr. Eric Wickstrom of the University of South Florida, were
passaged in RPMI 1640 supplemented with 1 ml/1 insulin-transferrin-selenium, 0.4
g/1 bovine serum albumin, gentamycin, and penicillin/streptomycin.

Cellular Proliferation and D ifferentiation.
HL-60 cells were resuspended in fresh growth medium at 1 to 2 x 10s
cells/ml in the presence of vehicle or an inducer of differentiation at the indicated
concentrations. At daily intervals thereafter, cell numbers were determined using
a Coulter Model ZBM particle counter (Coulter Electronics, Hialeah, FL).
Granulocytic differentiation was assessed by NBT reduction (13) and monocytic
differentiation by non-specific esterase staining, using a-naphthyl acetate as a
substrate (125).

For antisense oligodeoxynucleotide experiments, cells were

resuspended at 0.5 to 1 x IQ5 cells/ml and grown for 24 hr before the addition of
antisense DNA.

DNA Histogram s.
At indicated intervals, 106 cells were fixed in 70% ethanol and stored at 4°C
for up to 1 week.

Following RNase treatment, 30,000 cells were stained with

propidium iodide (0.05 mg/ml) as described by Crissman et al. (126). Briefly, 10s
cells were pelleted, washed once with cold PBS, three times with cold 95% EtOH,
incubated at 37°C for 30 min in 1 mg/ml ribonuclease type I-A in PBS, and stained
with 0.05 mg/ml propidium iodide in PBS for 30 min at 4*0.

Histograms of

relative cellular DNA content were obtained on a Becton-Dickenson FACS IV flow
cytometer.
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Im m unofluorescence of Surface T ran sfe rrin R eceptor.
At indicated intervals, IQ6 cells were removed, washed free of experimental
medium and incubated with or without FITC-conjugated monoclonal anti-human
transferrin receptor antibody at a 1:5 dilution in ice-cold culture medium for 30
min at 4°C. Cells were then washed twice with 1 ml of PBS at 4°C and fixed with
2% paraformaldehyde in PBS at 4°C. Cell-associated fluorescence was detected
using a Becton Dickenson FACS IV flow cytometer.

Relative amounts of cell

surface receptor were quantitated by calculating the linear difference in
fluorescence intensities between cells exposed and not exposed to the antibody.

U5I-T ransferrin Binding.
Radioligand binding to cell surface receptors was assessed according to the
method of Ishiguro (personal communication).

Human Tf, saturated with iron

using FeCynitrilotriacetic acid at a ratio of 1:2, was purified through a Sephadex
G-25 column equilibrated with 0.1 M NaC10« by the method of Bates and
Schlabach (127). Full saturation of Tf with iron was ascertained by an A^A^o
ratio of 0.045. The concentration of diferric Tf was determined spectroscopically
using an A ^ (1%) value of 14.0, and a molecular weight of 80 kD for Tf (128).
Diferric Tf (500 ug) was radioiodinated with 1 mCi Nat25I by the solid-phase
lactoperoxidase and glucose oxidase method and purified through a Bio-gel P-6DG
column, according to the procedure provided by the manufacturer.

Specific

activities of 126l-Tf ranged from 1,100 to 2,300 cpm/ng. HL-60 cells at a density of
1.3 x 107 cells/ml were incubated with ,26I-Tf in binding buffer (0.13 M NaCl, 5 mM
KC1, 2 mM MgClj, 25 mM HEPES (pH 7.4), 0.1% glucose, 5 mg/ml of bovine serum
albumin) for 1 hr on ice. Duplicate or triplicate 100 ul aliquots were layered onto
300 ul of a mixture of dibutyl phthalate and dinonyl phthalate (75.3:24.7, v/v) and
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cells were pelleted through the oil by a 15 sec centrifugation in an Eppendorf
microfuge (129). Aqueous and oil layers were aspirated and the tips of the tubes
containing the cell pellets were cut off. Radioactivity was determined using an
LKB-Wallac Compugamma counter.

The radioactivity found in the presence of

excess unlabelel Tf (1 mg/ml) was considered nonspecific and was subtracted from
the values obtained in the absence of unlabeled ligand (total binding) to obtain
specific binding.

Im m unoprecipitation of M etabolically L abeled TfR.
Cells were washed twice with methionine-free RPMI 1640 medium
containing 15% fetal bovine serum, suspended into the methionine-free medium at
a density of 1.5 x 107 cells/ml and labeled with [“ SJmethionine at a concentration
of 0.5 mCi/ml for the indicated intervals.

For pulse-chase studies to determine

cellular TfR t 1/2, cells were washed twice with normal growth medium and
resuspended at the initial cell densities in methionine-containing RPMI 1640 with
15% fetal bovine serum for varying periods of time. Labeled cells were washed
twice with PBS and lysed in an extraction buffer (50 mM Tris-HCl (pH 7.4), 150
mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 0.2 mM PMSF, 5 ug/ml aprotinin) at
a density of 1.5 x 107 cells/ml at 4°C for 5 min.

Lysates were clarified by

centrifugation at 12,000 x g at 4°C for 5 min. Total incorporation of the labeled
amino acid into proteins was monitored by precipitating macromolecules onto GF/C
filters (Whatman, Clifton, NJ) with 25% trichloroacetic acid and 2% casamino acids
following brief base hydrolysis with 1 N NaOH and 1.5% H20 2. Labeled TfRs were
isolated by immunoprecipitation using 10 to 15 ul of a monoclonal anti-human TfR
antibody at 4°C for 2 hr.

The immunocomplex was precipitated by 30 ul of

Protein-A-agarose (Pierce, Rockford, IL) at 4°C for an additional hour.
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immunoprecipitate was pelleted by centrifugation for 30 8 at 12,000 x g and
washed 4 to 5 times with 1 ml of the extraction buffer.

Finally, the

immunoprecipitate was boiled in sample buffer (0.1 M Tris-HCl (pH 6.8), 20%
glycerol, 2% SDS, 2% B-mercaptoethanol, 0.05% bromophenol blue) and analyzed
by SDS-PAGE by the Laemmli method (130) using a 5% stacking gel and a 7.5%
running gel. Following electrophoresis, the gels were fixed in 30% methanol and
10% acetic acid twice for 30 min. The gels were processed for fluorography by
impregnation with En3Hance for 30 min followed by precipitation with cold water
for 30 min. Dried gels were exposed to XKP-5 X-Omat film for autoradiography.

M easurem ent of T ransferrin R eceptor Specific mRNA.
At indicated intervals, total cellular RNA was extracted by a modification
of the guanidinium thiocyanate method of Chirwin et al. (131) as described
previously (63). Samples were evaluated, by dot blot or northern blot analyses.
For dot blots, aliquots of RNA (20 ug and successive 1:2 dilutions) were applied to
Gene Screen films via a 96-well manifold.

For northern blots, 10 ug of RNA

samples were subjected to electrophoresis in 1.2% agarose/formaldehyde gels and
then transferred to Gene Screen using 5 x SSC (1 x SSC is 0.15 M NaCl plus
0.015 M sodium citrate).

Samples were cross-linked to filters by brief UV

irradiation (132). Pre-hybridization was performed for 16 to 24 hrs at 42°C in a
solution containing 50% deionized form amide, 10% dextran sulfate, 1% SDS, 0.2%
bovine serum albumin, 0.2% polyvinylpyrrolidone, 0.2% Ficoll, 0.1% sodium
pyrophosphate, and 1 M NaCl in 50 mM Tris-HCl (pH 7.5) with 100 ug/ml of
denatured salmon sperm DNA. Hybridization reactions were conducted for 20 to
24 hrs in the same buffer at 42°C with 50 ng of a BamHl fragment from the
human TfR cDNA probe pcD-TRl (57) oligolabeled with [32P]dCTP by the method
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of Vogelstein (133).

Alternatively, a cDNA probe for

fi-actin, pAl (134), was

employed alone or hybridized simultaneously with the TfR cDNA probe. Filters
were washed with 2x SSC plus 0.5% SDS for 15 min at 25°C, 0.2 x SSC plus 0.2%
SDS for 20 min at 42°C, and 0.1 x SSC plus 0.5% SDS for 30 to 60 min at 60°C.
Dried filters were exposed to XRP-5 X-Omat film with an intensifying screen.
Developed films were analyzed by digital densitometry.

Synthesis a n d P u rificatio n of Phosphodiester Oligodeoxynucleotides.
Conventional phosphodiester oligodeoxynucleotides were synthesized using
standard solid phase phosphoramidite chemistry on an Applied Biosystems Model
380B DNA Synthesizer. After manual deprotection with concentrated NH4QH at
55°C overnight, the oligodeoxynucleotides were resuspended in distilled water and
subject to reverse phase liquid chromatography or HPLC purification. De-salting
was accomplished by a modification of the method of Lo et al. (135). Briefly, onehalf of the yield from a 1 micromole synthesis was resuspended into 100 ul of
distilled water and loaded onto a Sep-Pak cartridge (Waters Associates, Milford,
MA) previously equilibrated with 10 ml of acetonitrile followed by 10 ml of 10 mM
NH4QH. The cartridges were flushed with 10 ml of 10 mM NH4QH followed by
5 ml of air. The oligodeoxynucleotides were eluted with 3 ml of 20% acetonitrile
in distilled water with the majority of the sample being eluted within the first 1.5
ml. The eluate was evaporated to dryness in a Speed-Vac (Savant Instruments,
Farmingdale, NY) with concomitant application of heat.

Alternatively, equal

amounts of oligonucleotides were purified by HPLC using a Vydac C4 reverse phase
column (25 cm x 4.6 mm, 330-Angstrom pore size) (Separations Group, Hesperia,
CA).

The HPLC buffer system consisted of:

A= 100 mM triethylammonium

acetate (TEAC) and B= 100 mM TEAC + 50% acetonitrile.

Separation was
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achieved at a flow rate of 1 ml/min using a linear gradient from 0% to 50% "B"
over 40 minutes, with oligodeoxynucleotides eluting between 20 to 30 min (12% to
18% acetonitrile) depending upon length and G-C content. The detection system
consisted of continuous monitoring of sample absorbance at 254 run during
analytical runs or at 280 nm during preparative runs. The peaks containing the
full-length oligodeoxynucleotides were collected and evaporated to diyness as above.
Finally, purified samples were resuspended in PBS at a concentration of 1 mM
using Beer’s Law and an average nucleotide extinction coefficient of 10,000.
Samples were stored at -20°C.

S ynthesis an d P urification of Phosphorothioate Oligodeoxynucleotides.
Oligodeoxynucleotides with phosphorothioate linkages were synthesized using
nucleoside

3’-hydrogen

phosphonates

as

the

starting

reagents

and

1-

adamantanecarbonyl chloride as an activator (136,137,138) on an Applied
Biosystems Model 380B. After automated detritylation, the oligonucleotides while
still covalently attached to their solid support were treated with sulfurization
reagents as specified by the manufacturer (139). Briefly, the synthesis cartridges
were flushed for 3 hours at room temperature with a solution of 0.195 M S8 in
48% (v/v) carbon disulfide, 48% (v/v) pyridine, and 4% triethylamine.

Columns

were then flushed twice with carbon disulfide, three times with 2% triethylamine
in HPLC grade acetonitrile, and dried under vacuum. Modified oligonucleotides
were then cleaved from the solid support with concentrated ammonium hydroxide
and base deprotected with fresh concentrated ammonium hydroxide at 55°C for 10
hours. Phosphorothioate DNA was desalted using the Sep-Pak protocol outlined
above except that 60% acetonitrile in distilled water was used to elute samples
owing to the increased hydrophobicity imparted by the phosphorothioate linkages.
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HPLC purification was completed under conditions similar to the above, except that
buffer B= 100 mM TEAC + 60% acetonitrile and a linear gradient from 0% to
100% "B" was run over 30 min.

Under these conditions, de-protected

phosphorothioate oligodeoxynucleotides elute at 12 to 15 min (24% to 30%
acetonitrile) depending upon length and G-C content.

Dried phosphorothioates

were quantitated and resuspended at 1 mM in PBS as described above.

Serum Stability o f Oligodeoxynucleotides.
Synthetic DNA (1 ug) was first 5’-end labeled in a 10 ul reaction volume
using 6.6 pmoles of “ P-gamma ATP and 1 unit of T4 polynucleotide kinase
(Promega, Madison, WI) in a buffer containing 70 mM Tris-HCl (pH 7.6), 10 mM
MgCl2, 0.1 mM KC1, 5 mM dithiothreitol, 1 mM spermidine, and 66 uM cold ATP
at 37°C for 30 min.

Labeled oligodeoxynucleotides were then incubated, as

described, in various types of sera in the presence or absence of HL-60 cells for the
indicated periods of time. Aliquots of samplss were removed, denatured in sample
buffer (98% deionized formamide, 0.1% bromophenol blue, 0.1% xylene cyanole blue,
10 mM EDTA), and analyzed by polyacrylamide gel electrophoresis.

Samples

incubated in the presence of cells were first centrifuged at 12,000 x g for 1 min
to pellet cells before aliquots were taken.

Polyacrylam ide Gel E lectrophoresis o f Oligodeoxynucleotides.
End-labeled phosphodiester or phosphorothioate oligodeoxynucleotides were
analyzed by electrophoresis on a sequencing gel (20% polyacrylamide, 7 M urea,
90 mM Tris, 90 mM borate, 2 mM EDTA) at 300 volts.

End-labeled

oligonucleotide sizing markers from 8 bp to 32 bp were run as standards. Gels
were fixed and desalted by soaking twice for 1 hr in a solution of 40% methanol,
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10% glacial acetic acid, and 3% glycerol. Wet or dried gels were exposed to XRP5 X-Omat film for autoradiography.

C ellular U ptake of Oligodeoxynucleotides.
End-labeled phosphodiester or phosphorothioate oligonucleotides (106cpm/ml)
were incubated with HL-60 cells (2 x 10® cells/ml) at 37°C. At indicated intervals,
triplicate 200 ul aliquots were layered over 500 ul of a chilled (-20°C) mixture of
dibutyl phthalate and dinonyl phthalate (75.3:24.7, v/v) and cells were pelleted
through the oil by a 30 sec centrifugation in an Eppendorf microfuge. The aqueous
and oil layers were aspirated and the tips of the tubes containing the cell pellets
were cut off using dog toenail clippers.

Total cell-associated radioactivity was

assessed by liquid scintillation spectrometry. Duplicate samples were subjected to
acid-washing after aspiration to remove membrane-bound counts (140).

These

samples were resuspended with 0.75 ml of either 0.2 M acetic acid and 0.5 M NaCl
or 0.2 M glycine, vigorously vortexed, and incubated on ice for 5 min. Finally, the
cells were pelleted by centrifugation and processed as described above.

Cell-

associated radioactivity remaining after acid-washing was considered to represent
internalized oligodeoxynucleotides.
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RESULTS

Cell P roliferation an d D ifferentiation.
Exposure of HL-60 cells to inducers of differentiation resulted in an
inhibition of cell growth after different intervals of time that were characteristic
of the agent employed (Fig. 3). The phorbol ester TPA caused the most rapid
response, with cell stasis seen after only 12 hrs of treatment. Among the myeloid
inducers, ACM and DMSO inhibited cellular proliferation after the briefest interval,
with a cessation of growth occurring by 48 hrs.

RA exhibited a more gradual

effect, with cells displaying a loss of proliferative capacity only after 2 days of
treatment.

Changes in cell number are late consequences of any alteration to

cellular proliferation status.

Growth inhibition, alternatively, may be reflected

earlier by changes in the proportion of S-phase cells by propidium iodide staining.
However, significant changes in the DNA histograms of differentiating cells did not
precede observed changes in proliferation status as assessed by cell number (Fig.
4). A substantial shift to G/G, and away from S and Gj/M phases of the cell cycle
were seen in TPA- and DMSO-treated cells a t 24 and 48 hrs, respectively. ACM
appeared to cause an increase in S-phase cells at 24 hrs, with a subsequent
accumulation of G</G, cells by 48 hrs. RA caused only minimal changes in cell
cycle kinetics even at 48 hrs.
HL-60 cells are bipotent with respect to differentiation, being inducible along
either the granulocytic or monocytic/macrophagic pathways. These processes may
be quantitated by histochemical staining using NET dye reduction for granulocytic
or monocytic (13) differentiation and non-specific esterase (NSE) activity for
monocytic or macrophagic (125) maturation. In a manner analogous to that seen
with cell replication, the kinetics of cellular differentiation varied with the inducer
51
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Figure 3. Cellular growth kinetics of untreated and differentiating HL-60 cells.
Cells were exposed to vehicle (O); to granulocytic inducers, including 210 mM
DMSO (®); 1 uM RA

(A);

and 40 nM ACM (®); or to 50 nM of the macrophagic

inducer TPA (0). Cell numbers represent the mean of two determinations each
from at least three experiments.
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Figure 4. Cell cycle profiles of untreated and differentiating HL-60 cells. Cells
were treated with vehicle or to inducers of macrophagic or granulocytic
differentiation.

At the indicated times, cells were removed, fixed in ethanol,

treated with RNase, and stained with propidium iodide. Histograms of relative
cellular DNA content were obtained by fluorescence flow cytometry. The y-axis
indicates cell number and the x-axis indicates increasing fluorescence signal.
Panel A:

Cells at 12 hr after exposure of inducers of differentiation.

For

reference, the large peak seen with control cells represents G,/G, population. The
smaller peak represents the GJM. fraction.

The area between the twopeaks

approximates S-phase cells.
Panel B: Cells at 24 hr after exposure to inducers of differentiation.
Panel C: Cells at 48 hr after exposure to inducers of differentiation.
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employed (Fig. 5).

RA and TPA were potent inducers of granulocytic and

macrophagic differentiation, respectively, causing >90% of the cells to express the
appropriate phenotypic markers after 4 days of exposure.

The kinetics of

granulocytic differentiation induced by DMSO and ACM differed slightly from that
seen with RA, as shown by both the delayed onset of NBT positivity and the lower
maximum number of mature cells. Untreated HL-60 cells exhibited minimal NBT
reactivity during the course of the experiment. Similarly, control cells expressed
<5% positivity for NSE throughout the measured time course (data not shown).
Although the aquisition of a mature phenotype was accompanied by the
cessation of cellular proliferation, a strict temporal relationship between the two
was not always apparent. Thus, significant NBT reducing activity was expressed
and cell growth was inhibited virtually simultaneously after 48 hr in DMSO
treated cells.

However, the cessation of proliferation occurred long before the

appearance of appropriate marker activities in cells induced to differentiate with
TPA or ACM. Moreover, the relative rates of cellular maturation varied depending
upon the particular marker assayed. Consistent with the findings of Rovera et al.
(16), TPA-treated HL-60 cells acquired the ability to adhere to plastic.

In our

system, exposed cells first displayed adherence after only 8 hrs, with >90% of cells
becoming adherent by 24 hrs (data not shown).

These observations simply

underscore the complexity of the differentiation process, during which a variety of
cellular transformations must be completed, although not necessarily in an absolute
sequential fashion.

Surface TfR E xpression during D ifferentiation.
Cellular TfRs are localized in either internalized or surface membrane pools.
Clearly the latter represent the more physiological relevant sub-population since

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

59

Figure 5.

Differentiation of HL-60 cells induced along the granulocytic and

macrophagic inducers. HL-60 cells were exposed to vehicle (O); to granulocytic
inducers, including 210 mM DMSO (®); 1 uM RA

(A);

and 40 nM ACM (®); or

to 50 nM of the macrophagic inducer TPA (O), and differentiation was assessed by
nitroblue tetrazolium (--------) or nonspecific esterase (--------) staining.

Points

represent mean ± S.E. of at least three experiments, each done in triplicate.
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these receptors are actively involved in iron uptake and possible signal
transduction functions. Surface TfR expression can be conveniently assessed by
direct immunofluorescence using a fluorescein-labeled monoclonal antibody against
the human TfR. Cells stained in this manner can be analyzed for relative cellular
sTfR levels by use of a fluorescence activated cell sorter (FACS).

Typical

fluorescence histograms for uninduced, BMSO-treated, and RA-treated HL-60 cells
in which fluorescence intensity is plotted on a logarithmic scale are shown in
Figure 6. Uninduced cells stained with the labeled antibody are generally 80-100
fold more fluorescent than are non-stained cells. For quantitative comparisons, the
mean fluorescence intensity for differing populations of cells is interpreted as the
relative level of cellular sTfR expression for that population.
The expression of sTfR in untreated HL-60 cells was not constant, but
instead appeared to be correlated with the cellular proliferative status. After 5
days in culture, control cells no longer exhibited replicative activity and sTfR levels
decreased by 10-foid, compared to that seen at the beginning of the experiment
(Fig. 7).

However, even during the exponential phase of cell growth, receptor

expression was reproducibly altered. Consistent with the observations of Taetle et
al. (65), a biphasic change in surface receptors was seen during the first four days
of the experiment, when untreated control cells were increasing exponentially. A
virtual doubling of the levels of sTfR occurred during the first 24 hrs, followed by
a gradual return to initial levels during the next 3 days. It should be stressed
that the HL-60 cells employed in the present experiments were passaged at four
day intervals to ensure exponential growth, hence the initial rise in sTfR was not
a consequence of a stationary to growth phase transition of the cell cultures.
The relative amounts of membrane-associated TfR declined at various rates
when HL-60 cells are induced to differentiate. In agreement with the results of
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Figure 6. FACS profiles of sTfR expression in untreated and differentiating HL60 cells. Cells were exposed to vehicle or to inducers of granulocytic differentiation
for the indicated intervals.

Cells were then incubated with a fluorescein

isothiocyanate-conjugated murine monoclonal anti-TfR antibody at 4°C and fixed
in 2% paraformaldehyde in PBS under conditions specified by the manufacturer.
Samples were analyzed by fluorescence flow cytometry.
Tracings at right represent cellular fluorescence. Results are expressed with
increasing fluorescence intensity on the x-axis and absolute cell number on the yaxis. Uninduced cells (black), DMSO-treated cells (red), RA-treated cells (orange).
Tracings at left represent forward scatter which approximates cell size.
Upper Panel: Cells at 8 hr.
Lower Panel: Cells at 24 hr.
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Figure 7. Down-regulation of sTfR in untreated and differentiating HL-60 cells.
HL-60 cells were exposed to vehicle (O ); to granulocytic inducers, including 210
mM DMSO ( ® ); 1 uM RA ( A ); and 40 nM ACM ( ♦ ) ; or to 50 nM of the
macrophagic inducer TPA (•). Receptor expression was assessed as in Figure 6
with cellular autofluorescence substracted from anti-human TfR antibody-related
fluorescence. Points represent the mean of at least two experiments.
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May et al. (50), exposure to TPA elicited an extremely rapid reduction in receptor
expression. They demonstrated that ,26I-transferrin binding decreased by 50% after
only 60 min of TPA treatment. We have found that continued exposure to the
phorbol ester results in a further down-regulation of sTfR in excess of that
previously reported by May et al. (141). Although an overall 16-fold reduction in
surface receptor was observed during the entire course of the exposure to TPA,
most of this decrease in receptor expression occurred during the first 4 hrs of
induction.
The inhibition of TfK expression during myeloid differentiation occurred
more gradually, although levels of surface receptors ultimately declined to the
quantity present in TPA-treated cells.

Treatment of HL-60 cells with DMSO

always caused a minimal increase in sTfR levels during the first 8 hrs followed by
a pronounced decline, during which receptor levels approximated those of TPA
induced cells after 48 hrs.

RA reduced sTfR levels by 25% after only 4 hrs;

however, the subsequent inhibition of receptor expression occurred more slowly
than that seen with DMSO. ACM induced the most rapid decrease in surface
receptor activity among the myeloid inducers, with a 50% decrease in TfR being
obtained after 10 hrs.
Alternatively, cellular sTfR activity may be assessed by radioligand binding
at 4°C using ,2SI-Tf.

Direct immunofluorescence using the Becton-Dickensen

monoclonal antibody and 12SI-Tf binding provided comparable results. The extent
of TfR down-regulation during the induction of granulocytic differentiation with
DMSO or RA, as assessed by these two techniques, was quite consistent (Table 1).
Although a direct relationship between TfR expression and cellular
proliferative capacity has been demonstrated in other model systems (43,45), it
remains unclear whether sTfR modulation in differentiating leukemia cells is more
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TABLE 1

HL-60 sTfR Activity A sse sse d by
12Sl-Transferrin Binding or a Monoclonal Anti-TfR Antibody
During Granulocytic Differentiation

125

l-Tf bound (ng/10 cells)

Mean Fluorescence

Treatm ent

24 hr

Control

65 (100)

DMSO

14

(21)

3.5 (8.2)

46

(27)

12

(7.3)

RA

21

(32)

8.7 (21)

84

(47)

33

(20)

48 hr
42

(100)

24 hr
181 (100)

48 hr
167 (100)

Cells were treated with inducers or vehicle for the indicated time intervals and
sTfR w as a sse sse d by the two indicated methods.

DMSO w as employed at

175 mM for the ligand binding studies and at 210 mM for the fluoresceinated
antibody assay s.

RA w as used at 1 uM.

Values in parentheses represent

percentage of control.
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closely associated with the programmed termination of cellular replicative capacity
or with the initiation of the maturation process itself. The kinetics of sTfR downregulation in differentiating cells differed markedly depending upon the inducer
employed.

These relationships were quantitatively assessed by comparing the

duration of exposure to inducer which is required before significant cellular
alterations were observed. A four-fold decrease in sTfR, cessation of proliferation,
and the appearance of a mature phenotype in 25% of cells were arbitrarily chosen
as representative indices of the terminal differentiation process. Table 2 shows the
extrapolated durations before each of these milestones were reached in induced
cells. A temporal relationship existed between receptor down-regulation and the
eventual inhibition of growth, with the former always preceding the latter by 10
to 16 hrs.

TPA, which down-regulated sTfR most rapidly, inhibited cellular

proliferation in the shortest period of time. In contrast, RA exhibited the most
gradual effects on receptor expression and cell growth, with ACM and DMSO
evidencing an intermediate action. The temporal relationship between receptor
expression and the differentiated phenotype demonstrated pronounced inducerrelated variability and, in one case (RA), the appearance of the mature phenotype
preceded a significant reduction in sTfR levels.

TfR Message Levels d u rin g D ifferentiation.
Initial investigations of TfR mRNA levels using dot blot analyses suggested
that alterations in surface receptor are preceded by specific changes in transcript
levels. When total cellular RNA was covalently linked to nylon membranes and
hybridized to a “ P-labeled cDNA probe for the human TfR, an increase in the
relative amount of receptor message was apparent upon the subculturing of
uninduced HL-60 cells (Fig. 8). TfR mRNA peaked at 12 hrs, at which time
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TABLE 2

Effect of the Duration of Exposure to Inducers of Differentiation
on sTfR Down-regulation, Growth Inhibition, and Granulocytic and
Macrophagic Maturation of HL-60 Ceils

Time (hrs)
Treatm ent

sTfR (25%)

Growth Inhibition

Maturation (25%)

DMSO (210 mM)

38.2

48.0

58.6

RA (1 uM)

57.4

72.0

38.7

ACM (40 nM)

32.6

48.0

62.5

TPA (50 nM)

3.8

12.0

46.9

The time intervals required for the appearance of representative indices of HL60 leukemia cell differentiation, including: sTfR expression d ecre a se s to 25%
of initial values; cessation of cellular proliferation; and appearance of lineage
specific enzymatic activity in 25% of the total cell population, w ere derived from
Figures 3, 5, and 7.
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Figure 8. Dot blot of TfR and B-actin mRNA in untreated and DMSO-treated HL60 cells. Twenty ug and successive 1:2 dilutions of total cytoplasmic RNA from
cells grown in the absence or presence of DMSO (210 mM) were covalently bound
to a Gene Screen filter, hybridized with ^-labeled TfR probe, and subjected to
autoradiography. The filter was then stripped of remaining probe, rehybridized
with a ^-labeled probe to B-actin, and autoradiographed.
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approximately twice the amount of receptor transcript was present compared to
initial values. That the increase in TfR message was of the same magnitude as
and preceded the rise in surface protein suggested that the later event was
biosynthetically mediated at the mRNA level.

As a control, the dot blot

membranes were stripped of the TfR probe and rehybridized with a labeled cDNA
probe to B-actin. No significant changes were seen in the levels of B-actin gene
expression through 48 hrs in non-induced cells, indicating that changes in TfR
message were specific and were not a consequence of sample loading variability.
More detailed analyses of cellular transcript levels were possible by size
fractionation of ENA using denaturing gel electrophoresis followed by northern blot
hybridization. This technique permitted identification of mRNA species based upon
the expected molecular size of the transcript and ensured that excessive
degradation of RNA samples had not occurred. Previous work by Kuhn et al. (57)
has shown that TfR specific mRNA is 4.9 kb in length and migrates slightly above
the 28S ribosomal RNA band on formaldehyde/agarose gels. The TfR cDNA probe
did indeed hybridize with message at the expected molecular weight as shown in
Figure 9. The appearance of minor hybridizing transcripts is probably artifactual
and represents degradation of the TfR message. The area between the smaller
bands and the main TfR band corresponded exactly to the location of the 28S
ribosomal species. The overwhelming abundance of rRNA in this region may have
interfered with probe hybridization to the expected TfR mRNA degradative species.
Furthermore, consistent with our previous results using dot blot analysis, DMSO
induction led to a specific decrease in the amount of TfR transcripts (Table 3). No
significant change in message levels were seen until 8 hrs of treatment, whereupon
TfR specific transcripts declined dramatically through 24 hrs and remained minimal
through 48 hrs. Digital densitometry indicated that the steady-state levels of TfR
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F igure 9. Northern blot of TfR and B-actin mRNA in untreated, DMSO-, RA-,
and TPA-treated HL-60 cells. Ten ug of total cytoplasmic RNA from cells treated
for the indicated intervals with vehicle, DMSO (210 mM), RA (1 uM), or TPA (50
nM) were size fractionated in a 1.2% agarose/formaldehyde gel, transferred onto
Gene Screen filters, hybridized with '^P-labeled probes specific for TfR and B-actin,
and subjected to autoradiography.
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TABLE 3

Densitometric Quantitation of Relative mRNA Levels during
Granulocytic and Macrophagic HL-60 Cell Differentiation

TfR/Actin Ratio
Hrs of exposure

Control

DMSO

RA

TPA

4

0.31

0.31

0.39

0.45

8

0.57

0.31

0.61

0.57

12

0.40

0.15

0.43

0.42

24

0.41

0.07

0.33

0.02

48

0.27

0.10

0.04

0.07

The autoradiogram shown in Figure 9 was scanned by digital densitometry and
the results are expressed as a ratio of the TfR to B-actin values.
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mRNA declined to 50% of initial levels by 12 hrs of DMSO exposure. Comparison
with Figure 7 indicates that this decrease in transcripts preceded by 12 hrs similar
reductions at the protein level. Since B-actin mRNA is 2 kb, hybridization with
both the TfR and B-actin probes can be performed simultaneously. In a manner
analogous to that seen in uninduced cells, levels of B-actin transcripts did not
change appreciably during the first 48 hrs of DMSO treatment.

In addition,

DMSO and the other inducers used did not significantly alter the cellular
ribosomal RNA content, as visualized by staining agarose/formaldehyde gels with
acridine orange (data not shown).
Consistent with the gradual decline in surface TfR in RA-induced cells, the
reduction in steady-state levels of receptor transcripts was a relatively late event.
Interestingly, the amount of TfR message in these cells increased in parallel to
that seen with control cells during the first 8 hrs of treatment.

This finding

contrasted with the slight reduction in surface receptor levels seen during this
period.

RA-treated cells began evidencing decreased levels of TfR transcripts

relative to control by 12 hrs, with the most pronounced reduction occurring by 48
hrs, when sTfR was also markedly down-regulated.
ACM produced an immediate reduction in TfR message (Figure 10, Table 4).
When equivalent time points were compared to sTfR expression (Figure 7), the
decline in TfR transcripts, as quantitated by densitometry, were seen to precede
that occurring at the protein level by 4 hrs, suggesting that the TfR downregulation was at least in part mediated by a reduction in the steady-state level
of mRNA.

The inhibitory effects of this anthracycline on lipid-linked

oligosaccharide biosynthesis have been indirectly implicated as a postulated
mechanism of the decreased sTfR activity by Morin et al. (49).

In fact,

granulocytic differentiation by DMSO, RA, and ACM appear to have as a common
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F ig u re 10.

Northern blot of TfR and B-actin mRNA in untreated and ACM-

treated HL-60 cells. Ten ug of total cytoplasmic RNA from cells treated for the
indicated intervals with vehicle or ACM (40 nM) were size fractionated in a 1.2%
agarose/formaldehyde gel, transferred onto Gene Screen filters, hybridized with 32Plabeled probes specific for TfR and B-actin, and subjected to autoradiography.
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TABLE 4

Densitom etric Quantitation of Relative mRNA Levels during
ACM-induced Granulocytic Differentiation of HL-60 Leukemia Cells

TfR/Actin Ratio
Hrs of Exposure

Control

ACM

0

0.51

0.52

4

0.37

0.31

8

0.63

0.20

12

0.43

0.11

24

0.35

0.10

48

0.20

0.08

The autoradiogram shown in Figure 10 was scanned by digital densitometry and
the results are expressed as a ratio of the TfR to 13-actin values.
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attribute the down-regulation of sTfR, which is kinetically compatible with reduced
receptor biosynthesis secondary a decrease in TfR transcript levels.
In contrast to the above findings, the initial down-regulation of sTfR during
macrophagic differentiation by TPA (Figure 9, Table 3) was clearly not attributable
to reduced transcripts. In fact, an increase in TfR mRNA occurred through the
first 12 hrs in spite of drastic reductions in surface receptor content, which
presumably resulted from an intracellular redistribution.

May et al. have

demonstrated that this phorbol ester-induced receptor redistribution does not result
in any alteration in the total amount of cellular TfR protein (50).
Alternatively, an increased rate of TfR protein catabolism may contribute to
the down-regulation of TfR seen during differentiation. This hypothesis was tested
by pulse-chase labeling of whole cells with “S-methionine. After a 4 hr pulse, HL60 cells were washed free of the metabolic label and resuspended into medium
containing cold methionine. During the 24 hr chase period, cells were periodically
lysed and TfR protein half-life was monitored by immunoprecipitation and SDSpolyacrylamide gel electrophoresis. An increase in the turnover of TfR protein was
not seen in DMSO-treated cells over uninduced cells (Fig. 11).

This finding

supports the view that biosynthetic alterations, perhaps relating to transcriptional
regulation, underlie the down-regulation of TfR seen during the chemically-induced
differentiation of HL-60 leukemia cells.

M onocytic D ifferentiation Induced by 10 ,2 5-dihydroxy vitam in D„.
Monocytic maturation, in contrast to granulocytic and macrophagic
differentiation, is not, by definition, a terminal differentiation program. Although
these cells may express mature phenotypic markers, irreversible loss of proliferative
potential is not a concomitant event. Indeed, HL-60 cells continuously exposed to
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F igure 11.

TfR protein half-life in untreated and differentiating HL-60 cells.

Cells were pulse labeled with “ S-methionine for 4 hours and chased in culture
media containing cold methionine for the indicated intervals. Lysates, prepared by
solubilizing whole cells with 0.5% NP-40, were then immunoprecipitated with a
murine monoclonal anti-human TfR antibody and protein-A-agarose. Samples were
finally analyzed by SBS-polyacrylamide gel electrophoresis and fluorography.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

Chase (Hr):

0

6

12 24

CONTROL

0

6

12 24

DMSO

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

83

100 nM la,25-dihydroxyvitamin D3 for 6 days exhibited the same proliferative rate
as untreated controls (Fig. 12). Induced cells did differentiate as evidenced by the
progressively increased percentage of cells expressing the differentiation markers,
NBT and NSE (Fig. 13).

In contrast with macrophagic maturation induced by

TPA, la,25-dihydroxyvitamin D3-treated HL-60 cells weakly expressed non-specific
esterase activity and did not adhere to plastic. Down-regulation of sTfR was a
relatively late event in this system. A signficant difference between induced and
uninduced cells was evident only after 48 hr of exposure (Fig. 14).

More

importantly, a decrease in sTfR expression to 25% of initial levels (see Table 2)
was apparent only during the last day of the experiment.

Observed in both

uninduced and treated cells, this late TfR down-regulation event is probably
secondary to plateau phase growth due to high density culture conditions.
These experiments with lo,25-dihydroxyvitamin D3 support the preceding
hypothesis that TfR down-regulation during the terminal differentiation of HL-60
cells is more closely associated with cessation of cellular proliferation than with the
acquisition of the mature phenotype. A significant and early down-regulation of
TfR in induced cells was not apparent during monocytic differentiation with la ,25dihydroxyvitamin D3. Consequently, although HL-60 cells induced with this agent
expressed enzymatic activities and morphology characteristic of monocytes, cell
growth was not inhibited.

Calcium Channel Blockers Potentiate TfR Down-Regulation by Inducers
of Differentiation.
It has been previously noted that TfR induction is a requisite event during
the activation of T-lymphocytes by mitogens (45). In normal resting T-cells, the
TfR gene is transcriptionally silent. The mitogenic stimulus provided by
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F igure 12. Growth kinetics of HL-60 cells induced with la,25-dihydroxyvitamin
Da. Cells were treated with vehicle or 100 nM la,25-dihydroxyvitamin D3. Cell
counts were determined as described in the legend to Figure 3.
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Figure 13. Differentiation of HL-60 cells induced with la,25-dihydroxyvitamin D3.
Cells were treated with vehicle or 100 nM la,25-dihydroxyvitamin D3.
Differentiation was assessed on days 3 and 6 by NET or NSE staining as described
in the legend to Figure 5.
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F igure 14. sTfR alterations in HL-60 cells induced with la,25-dihydroxyvitamin
D3. Cells were treated with vehicle or 100 nM la,25-dihydroxyvitamin D3. sTfR
was assessed at daily intervals as described in the legend to Figure 7.
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phytohemagglutinin and phorbol esters results in the sequential activation of the
genes for the interleukin-2 receptor and T£R. Further dissection of this system has
revealed that calcium plays a role in the regulation of lymphocyte proliferation.
Mobilization of intracellular calcium and an influx of extracellular calcium are seen
during mitogenesis.

In some instances, the calcium ionophore A23187 may

substitute for the requirement for tissue-specific growth factors, such as
interleukin-2 (142). These observations led Neckers et al. to investigate the effects
of diltiazem, a calcium channel blocker, on the T-cell activation cascade (143).
Diltiazem at 100 uM was found to prevent the induction of TfR mRNA and protein
in normal T-cells and caused a progressive loss of TfR mRNA and protein in a
malignant T-cell line. Cells treated by this agent subsequently exhibited growth
arrest in the G, phase of the cell cycle. These phenomena were also observed in
cells treated with EGTA, further supporting the role of calcium in the induction
of TfR biosynthesis during T-lymphocyte activation.
Since both diltiazem and the inducers of leukemia cell differentiation
inhibited TfR expression, we attempted to determine if these agents would
synergistically act to down-regulate TfR expression in HL-60 cells. As shown in
Table 5, diltiazem or verapamil at 100 uM as well as diltiazem at 50 uM markedly
inhibited sTfR expression.

The addition of sub-optimal concentrations of

differentiation inducers, including RA at l/100Qth of the usual inducing dose,
resulted in an additive suppression of surface TfR.

These data raise the

interesting possibility of using combinations of agents, perhaps including calcium
channel blockers, which inhibit TfR expression by independent mechanisms to
potentiate the inhibition of proliferation of neoplastic cells.
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TABLE 5

S y n erg istic Effect of Calcium C hannel B lockers an d
S ub-optim al C o n cen tratio n s of Differentiation Inducers
on HL-60 sTfR Levels

125l-Tf bound (% of Control)

Inducer
None

Control
100

Diltiazem

Diltiazem

Verapamil

(50 uM)

(100 uM)

(100 uM)

41.0

25.3

11.8

RA - 1 nM

49.7

22.1

14.7

n.d.

DMSO - 0.5%

22.5

8.8

3.1

n.d.

DMSQ - 0.75%

9.1

n.d.

8.1

3.5

Cells were treated with vehicle, inducers, or calcium channel blockers for
4 days. Relative sTfR levels were a sse s se d by steady-state cellular binding of
125l-Tf at 4°C.
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Uridine and Thymidine Incorporation.
To determine whether the down-regulation of TfR mRNA seen during the
chemically-induced differentiation of HL-60 cells was a result of a non-specific
suppression of RNA synthesis, cells were pulse labeled with *H-uridine and assayed
for incorporation of the radiolabeled nucleotide into macromolecules. A significant
inhibition in ^-uridine incorporation was not seen until after 24 hr in cells treated
with DMSO (Fig. 15).

It may be recalled that TfR transcript levels began to

decline as early as 8 hr after the exposure of cells to DMSO (Table 3). Similarly,
cells treated with RA incorporated *H-uridine at levels similar to that of control
cells even after 48 hr of exposure. In contrast, the level of TfR message in RAtreated cells at 48 hr were 15% that of control cells (Table 3).

Clearly, the

decreases noted in the level of steady-state TfR transcripts were specific and did
not result from a generalized inhibition in RNA synthesis during the differentiation
of these cells. The rate of 3H-thymidine incorporation in these cells is shown for
reference (Fig. 16).

Relative to uninduced cells, differentiating cells exhibited

decreased levels of 3H-thymidine incorporation before equivalent changes were seen
in the levels of 3H-uridine incorporation.

Modulation of Growth and Differentiation by Iron and Iron Chelator.
The results presented above suggested that the down-regulation of TfR seen
during the terminal differentiation of HL-60 cells was more closely associated with
cessation of cellular proliferation than with acquisition of the mature phenotype.
Since the primary role of TfR is to mediate iron uptake into cells, we asked
whether manipulation of iron availability, through the addition of exogenous iron
or iron chelators, would affect the induction of differentiation. Specifically, since
agents such as DMSO and RA promote TfR down-regulation, which leads to

R ep ro d u ced with p erm ission of th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

93

Figure

15.

3H-tJridine incorporation during granulocytic and monocytic

differentiation. Cells were removed after exposure to inducers for the indicated
intervals, pulse-labeled for 1 hr with 2 uCi 3H-uridine, washed with PBS, and
collected on Whatman GF/C filters. Cellular macromolecules were precipitated with
ice-cold 10% trichloroacetic acid.

Filters were washed with distilled water and

ethanol and then quantified by liquid scintillation spectrometry. Data represent
the mean ± S.D. of triplicate determinations.
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Figure 16.
differentiation.

‘’H-Thymidine incorporation during granulocytic and monocytic
Cells were removed after exposure to inducers for the indicated

intervals, pulse-labeled for 1 hr with 2 uCi ^-thymidine, washed with PBS, and
collected on Whatman GF/C filters. Cellular macromolecules were precipitated with
ice-cold 10% trichloroacetic acid.

Filters were washed with distilled water and

ethanol and then quantified by liquid scintillation spectrometry. Data represent
the mean ± S.D. of triplicate determinations.
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decreased cellular iron uptake and terminal differentiation, would increasing the
amount of bioavailable iron to cells inhibit differentiation?
Varying concentrations of bioavailable iron, present in a molar ratio of 1:2
with nitriloacetate, were added to HL-60 cells exposed to 210 mM DMSO or to
vehicle. A biphasic effect on cellular growth was seen (Fig. 17, upper panel). At
concentrations up to 10 uM FeCl3, cell growth was stimulated by up to 50%. From
10 uM to 1 mM of FeCl3, however, a dose dependent inhibition of cell growth was
apparent. Evident in both control and induced cells, this was presumably related
to iron toxicity.

In contrast, addition of iron did not significantly modify the

induction of NET positivity by DMSO throughout the concentration range tested
(Fig. 17, lower panel).
The inverse question may be asked.

Does the simulation of TfR down-

regulation by chelation of extracellular iron with deferrioxamine (Desferal) induce
maturation by itself or enhance differentiation using sup-optimal concentrations of
inducers? Thus, cells induced with optimal doses of DMSO (210 mM) or RA (luM)
or with sub-optimal doses (105 mM DMSO or 1 nM RA or 10 nM RA) of
differentiating agents were exposed to concentrations of Desferal up to 10 uM.
Regardless of the presence or absence of DMSO or RA, cells exposed to 10 uM
Desferal proliferated at a rate approximately 25% that of untreated cells (Fig. ISA,
upper panel; Fig. 18B, upper panel).

The growth inhibitory effects of the iron

chelator were dose dependent. Desferal, like exogenous FeCl3, did not appreciably
alter the degree of maturation observed with varying doses of inducers of
differentiation (Fig. 18A, lower panel; Fig. 18B, lower panel).
These results support the hypothesis that a consequence of TfR downregulation during the terminal differentiation of HL-60 cells is the inhibition of
growth without attendent effects on cellular maturation. The reduction of
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F igure 17. Effect of exogenous Fe on HL-60 growth and differentiation. Cells
were exposed to 210 mM DMSO or vehicle and to varying concentrations of
FeCl3:nitriloacetate (1:2) for 5 days.
Upper panel: Cell proliferation
Lower panel: Differentiation as assessed by NBT staining. Values represent the
mean ± S.D. of triplicate determinations.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

99

160
D M SO

140

Uninduced
C ontrol: n o addition o f Fe

120

£

100

t-*

80

o

— 60
E
° 40
20

10

01

100

1000

uM Fe
100

80

e
■2

a

60

c

<u
DM SO

40

Uninduccd

a
20

01

10

100

uM Fe

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

1000

100

Figure 18. Effect of deferrioxamine on HL-60 growth and differentiation. Cells
were exposed to vehicle or inducers of granulocytic differentiation at the indicated
concentrations and to varying concentrations of the iron chelator, deferrioxamine
(Desferal), for 4 days. Cell growth and differentiation was assessed by methods
described in Figure 17 legend.
A (Upper panel): Desferal and DMSO. Cell proliferation.
A (Lower panel): Desferal and DMSO. Cell differentiation. Values represent the
mean ± S.D. of triplicate determinations.
B (Upper panel): Desferal and RA. Cell proliferation.
B (Lower panel): Desferal and RA. Cell differentiation.

Values represent the

mean ± S.D. of triplicate determinations.
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bioavailable iron to the cell through TfR down-regulation or extracellular Desferal
did not increase the number of NBT positive cells, either alone or in concert with
DMSO or RA. Conversely, the addition of exogenous iron, up to toxic levels, did
not inhibit the ability of DMSO, which reduces levels of sTfR, to induce
maturation.

However, manipulation of extracellular iron levels markedly

modulated the cellular growth of uninduced and induced cells.

Iron

supplementation up to 10 uM stimulated growth, whereas iron chelation resulted
in marked growth inhibition.
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Biological Efficacy o f Phosphodiester Antisense O ligonucleotides.
The hypothesis that TfR down-regulation triggers the inhibition of cell
growth without inducing phenotypic differentiation in HL-60 cells is inferential.
The arguments presented above rest on temporal associations and involve the use
of differentiation agents which may have multiple actions within the cell in
addition to down-regulating sTfR.

Clearly, the diverse chemical classifications

which encompass the inducers of differentiation, ie. DMSO, RA, ACM, TPA, la ,25dihydroxyvitamin D3, suggest that they may possess a disparate spectrum of
biochemical activities in the cell. In order to employ a novel alternate means of
specifically inhibiting sTfR expression, antisense oligonucleotides were generated
against the human TfR mRNA.
The TfR mRNA is organized into a 2.3 kb coding sequence, flanked by 0.28
kb and 2.6 kb untranslated regions at the 5’ and 3’ ends, respectively (57,59).
Antisense oligonucleotides of 17- and 30-mer length were synthesized against target
sites in the regions of the initiation codon, a 5’ upstream site at -50 bp relative to
the initiation codon, and the 5’ cap site of the TfR mRNA (Fig. 19).

In many

cases, identical sequences in the phosphodiester and phosphorothioate series of
oligomers were generated. Sense oligomers or scrambled sequence oligomers in
which the final base composition of the molecules was unchanged from its
antisense congener were synthesized as presumptive negative controls. In addition,
previously well-characterized antisense oligonucleotides directed against c-myc and
VSV target sites were also synthesized (91).
Mathematical algorithms have been developed to predict folding of single
stranded RNA based upon thermodynamic considerations (144,145).

A two-

dimensional map showing the theoretical folding of the first 1000 bases of the
human TfR mRNA revealed extensive secondary structure and potential sites of
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F ig u re

19.

Human

TfR

mRNA

map

and

sequences

of antisense

oligodeoxyribonucleotides.
Top. A map of the human TfR mRNA is shown schematically. The 2.3 kb coding
sequence is flanked at the 5’ end by a 0.3 kb untranslated segment and at the 3’
end by a 2.6 kb untranslated region. The target sites of antisense oligonucleotides
are shown with nucleotide sequence numbers expressed relative to the initiation
codon.
Bottom: The antisense oligonucleotides employed in these experiments along with
their target site, sequence data, and intemucleotide bond type are indicated.
Normal phosphodiester oligomers are denoted as PO, whereas phosphorothioate
analogues are denoted as PS. Antisense, sense, and scrambled sequence oligomers
were synthesized. The number of mismatched bases in the scrambled sequence
oligomers are denoted. Antisense DNA against TfR were 17 or 30 bases in length;
oligonucleotides against c-myc or VSV were 15-mers.
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5' untranslated
region

TfR coding sequence

I

3' untranslated
region

1

30

initiation codon: ATG ATG GAT CAA GCT AGA TCA GCA TTC TCT
-51

-22

5’ upstream: GCT GTG GCG GCG CCT CGA GCG GCT GCA GGT
-282

-266

cap site: GAG CGT CGG GAT ATC GG

Location

Oliaomer

S eauen ce

Anti-sense
"

Anti-sense
"

A C C TG C AGC CGC TCG AGG CGC CGC CAC AGC

PO
PS
PS

TTF7
TTF8

CC G A T A T C C CGA CGC TC
CC G A CA T T C CGT CCC GA

PS
PS

Anti-sense
Mismatch (6)

MY1
TMY1
MYS
TMYS

AAC G T T GAG GGG CAT

PO
PS
PO
PS

Anti-sense

C T A GCT TGA T C C A T C AT

TF2
TTF2
TTF4

CGA GGC G CC G CC ACA GC

Cap site

Init. codon- Myc

5’ upstream

Im

PO
PS
PS
PO
PS
PS
PS

TF1
TTF1
TTF9
T1S
TT1S
TTF5
TTF6

Initiation codon

lin k a a e

tt

C T A A C T T C A ACC T T G GT
ATG A T G GAT CAA GCT AG
tt

AGA GAA TG C TGA T C T AGC TTG A T C CAT CA T
AGA GAA C G T T C T T C T ATC TTG AAG ACA CG T

*•

tt

A T G C C C C T C AAC GTT
ft

Mismatch (6)
Sense
Anti-serise
Mismatch (11)

it

11

Sense

Init. codon-VSV

VSV

T T G GGA TAA CAC TTA

PO

Anti-sense

Random sequence

TTGT

TG T GTG TG T GTG TGT GT

PS

Random

R e p r o d u c e d with p e r m i s s io n of t h e co p y rig h t o w n er. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

107
intramolecular hybridization (Fig. 20).

Presumably, large stem loop structures

present on transcripts should provide attractive targets for antisense inhibition of
gene expression since contiguous segments of single stranded mRNA are available
for heteroduplex formation. For example, the TfR initiation codon occurs several
bases proximal to a large potential stem loop structure, indicated between bases
270 and 280 in Figure 20. The antisense oligomer, TF1, was designed to hybridize
to this region of message.
Initial experiments focused on the effects of phosphodiester antisense
molecules on sTfR expression and cellular proliferation in the parental HL-60 cell
line which was grown in serum-containing culture medium.
molecules were first assessed for activity.

Three antisense

MY1 was identical to the anti-myc

pentadecamer employed by Wickstrom (91) and Holt (92).

TF1 and TF2 were,

respectively, 17-mers targeted to the initiation codon and a 5’-upstream region at
-50 bases from the initiation codon of the human TfR mRNA. A surprising range
of biological efficacy was evident when these phosphodiester oligonucleotides were
tested for activity. At 50 uM, MY1 had little effect on cellular proliferation and
sTfR expression, whereas TF1 inhibited sTfR levels by greater than 80% after 24
h r and suppressed cell growth by 90% after 72 hr compared with vehicle-treated
controls (Fig. 21).

TF2 displayed an intermediate effect.

Surprisingly, cell

viability, as assessed by trypan blue exclusion after 72 hr of oligomer exposure,
parallelled the levels of growth inhibition. This suggested that the mechanism of
growth inhibition might be frank cytotoxicity by the oligonucleotides or by an
unknown contaminant. These initial experiments employed oligonucleotides which,
other than being lyophilized twice, were not purified after recovery from the DNA
synthesizer. This strategy was based upon some of the early antisense literature
which described the use of oligonucleotides prepared in this manner as appropriate
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Figure 20. Theoretical folding of TfR mRNA molecule. The first 1000 bases from
the Genbank file HUMFTRRA, which contains the sequence for the human TfR
cDNA, were evaluated by the FOLD algorithm of Zucker (144,145). The resultant
predicted secondary structure was plotted using the SQUIGGLES program.
Computer-derived manipulations were performed using the Sequence Analysis
Software Package from the Genetic Computer Group at the University of Wisconsin
Biotechnology Center.
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F igure 21.

Effect of crude TfR antisense oligodeoxyribonucleotides on HL-60

growth, viability, and sTfR. HL-60 cells grown in FBS-containing medium were
exposed to vehicle or to 50 uM oligomer. Levels of sTfR were assessed by binding
of a fluoresceinated anti-human TfR monoclonal antibody after 24 hr exposure to
oligonucleotide. Cell counts and cell viability was assessed after 72 hr incubation
with oligonucleotide.
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reagents for tissue culture (98).
To distinguish between oligonucleotide-mediated growth inhibition versus
cytotoxicity, the oligonucleotides were digested with DNase I prior to incubation
with HL-60 cells.

The rationale for this experiment was that if the biological

activity of the oligonucleotides was mediated by an antisense mechanism, then
DNase I digestion should abolish any biological effect of these oligomers. Retention
of significant sTfR or growth inhibitory activity after enzymatic hydrolysis of these
molecules would suggest that these effects were not being mediated by the
oligonucleotides as antisense agents. Short oligonucleotides can be analyzed and
sized by denaturing gel electrophoresis using polyacrylamide gels impregnated with
7M urea. These denaturing conditions are crucial in permitting the separation of
oligonucleotides based primarily on size considerations since intrastrand folding of
DNA may result in artifactual rates of electrophoretic migration.
The undigested parental oligomers appeared as distinct single bands at the
expected molecular weights, suggesting that their synthesis proceeded with high
coupling efficiencies and that they were free of prematurely terminated species
(Fig. 22, lanes 2,5,10-12).

Exposure of the oligomers to DNase I resulted in

substantial digestion of the parental 15- or 17-mers to sequences smaller than 7mers using high concentrations of enzyme (Fig. 22, lanes 3 & 6) or smaller than
or equal to 9-mers using low concentrations of enzyme (Fig. 22, lanes 4 & 7).
These short sequences should be too short to specifically interact with single target
sites within the eukaryotic genome, hence should not possess intrinsic antisense
activity. However, these hydrolyzed oligonucleotides displayed comparable levels
of growth inhibition with that of the undigested species (Fig. 23). This suggested
that the original observations noted in Figure 21 were not mediated by the
oligonucleotides as antisense agents. Since initial purification was not performed
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F igure

22.

Electrophoresis

oligodeoxyribonucleotides.

of

DNase

I

digested

TfR

antisense

Synthetic DNA was hydrolyzed with DNase I from

Promega (1 U/ul) or from Worthington Biochemicals (12.5 U/ul) for 3 hr at 37°C,
5-end labeled with T4 polynucleotide kinase and ^-A T P , and analyzed by
denaturing polyacrylamide gel electrophoresis and autoradiography.
Lane 1 & 9: Oligonucleotide sizing markers.
Lane 2 & 11: TF1, undigested.
Lane 3:

TF1,

digested withDNase I

(Worthington).

Lane 4:

TF1,

digested withDNase I

(Promega).

Lane 5 & 12: TF2, undigested.
Lane 6:

TF2,

digested withDNase I

(Worthington).

Lane 7:

TF2,

digested withDNase I

(Promega).

Lane 10: MY1, undigested.
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F igure 23. Effect of DNase I pre-treatment on TfR antisense activity. Crude and
hydrolyzed oligomers prepared as described in Figure 22 legend were incubated
with HL-60 cells in FBS-containing medium at 50 uM for 3 days. Cell number
and viability was determined as described in Figure 21 legend.
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on these oligomers, it was possible that a contaminant from the synthesis of the
oligonucleotides, perhaps an organic salt or cleaved protecting group, remained as
a cytotoxic agent responsible for the biological effects seen.

HPLC Purification o f O ligonucleotides.
The purification of synthetic oligonucleotides as potential antisense agents
was deemed necessary due to the artifactual results generated by the crude
oligomers in tissue culture. The common techniques employed for this purpose
include denaturing polyacrylamide gel electrophoresis, ethanol precipitation, and
HPLC.

Electrophoresis, although a highly efficient technique, was disregarded

because it is only suitable for small (microgram) amounts of oligonucleotide and
because of poor recovery.

Ethanol precipitation, while permitting batch-wise

desalting of large amounts of synthetic DNA can only be performed with oligomers
greater than 50 bases in length.

HPLC, although labor intensive, was chosen

because it yields high recovery while allowing milligram amounts of sample to be
purified during each run.

A purification system based on reverse phase

chromatography was selected based on information supplied by Applied Biosystems
(146). A C4 column possessing large pores (330 A) was chosen to allow maximal
interaction between the relatively large, linear oligonucleotides (Mwt approx. 510 kD) and the column matrix.
Although all oligonucleotides were subjected to HPLC purification,
representative chromatographic tracings of a phosphodiester (TF1) and a
phosphorothioate (TTF6) oligomer using uV absorption as the detection system are
shown (Fig. 24). Several comments can be made. This system is both efficient
and sensitive as shown by the relative lack of prematurely terminated species (n1-mers, n-2-mers, etc.), which appear as small peaks at the base of the single large
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Figure 24. HPLC purification of TfR antisense molecules using C4 reverse phase
chromatography. Representative HPLC tracings of a phosphodiester 17-mer (TF1)
and a phosphorothioate 30-mer (TTF6) and the percentage of acetonitrile (ACN)
required for elution are shown. Detection was by uV absorption at 254 nm.
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peak which corresponds to the parental oligomer. Elution from the column was
dependent on several factors. Oligonucleotide size and intemudeotide bond type
were the primary determinants of the percentage of acetonitrile required for
elution. Larger oligomers were retained longer on the column. Phosphorothioate
sequences, which possess reduced polarity, have stronger hydrophobic interactions
with the column matrix, hence were also retained longer. Finally, oligonucleotides
having a higher G-C content generally eluted slower.
HPLC purification resulted in negligible changes to the electrophoretic
pattern of oligomers (Fig. 25). As expected, there was no change in the location
of the parental band on a polyacrylamide gel compared to oligonucleotide sizing
markers. Moreover, the relative amounts of prematurely terminated sequences,
represented as bands of smaller molecular weight, did not change. This indicated
that the parental oligomer was, by far, the dominant speries and that the
contribution of smaller incompletely polymerized oligonucleotides to the total pool
was trivial.

However, that no gross change was seen in the electrophoretic

patterns did not exclude the removal of contaminating inorganic or organic salts
after HPLC purification. Indeed, when fractions from an HPLC run were collected,
lyophilized, resuspended into buffer, and added to cell cultures, a single fraction,
which eluted well before the parental oligonucleotide, displayed potent growth
inhibitory effects (Fig. 26). Fraction number 4, which corresponded to the first
fraction to be eluted from the column, must contain extremely hydrophilic
compounds.

This confirmed that a low molecular weight salt(s), probably a

blocking group involved in oligomer synthesis, was the likely contaminant.
Antisense phosphodiester oligonucleotides, which had been purified by this
HPLC protocol, were assayed for sTfR and growth inhibition. Initial experiments
with these molecules showed inactivity in the parental HL-60 cell line. As will be
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F ig u re 25.

Electrophoresis of crude and purified antisense DNA.

Crude and

HPLC-purified phosphodiester oligonucleotides prepared as described in Figure 24
legend were analyzed by 5’-end labeling, denaturing polyacrylamide gel
electrophoresis, and autoradiography. Oligonucleotide sizing markers are shown
at left.
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F igure 26. Toxicity of HPLC fractions of crude antisense oligodeoxynucleotides to
HL-60 cells.

10 nmoles of crude TF1 was purified by HPLC.

Fractions were

collected at 1 min intervals, evaporated to dryness, resuspended into PBS and
added to 200 ul serum-free ITS media with HL-60 cells (2 x 105 cells/ml). Cell
growth was assessed after 72 hr.
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discussed below, one potential reason for this result is the presence of serum
nucleases which rapidly hydrolyze, and thereby inactivate, phosphodiester
oligonucleotides (105,147).

For this reason, a similar set of experiments was

conducted on an HL-60 cell line adapted to grow under serum-free culture
conditions and generously supplied by Dr. Eric Wickstrom.

At concentrations up

to 50 uM, none of the phosphodiester antisense oligonucleotides inhibited sTfR
expression in HL-60 cells after 24 hr of incubation (Fig. 27). Further exposure of
cells to these oligonucleotides for 48 hr likewise did not result in any TfR
inhibition (data not shown). Not surprisingly, growth inhibition in these cultures
treated with oligomer was not apparent through 4 days (data not shown).

Synthesis o f and Purification o f Phosphorothioate O ligonucleotides.
That the phosphodiester oligomers proved ineffective as antisense inhibitors,
even in the presence of serum-free medium, stimulated efforts to synthesize and
assess oligonucleotide analogues. The phosphorothioates were selected because of
their resistance to nuclease hydrolysis, presumed advantages in cellular uptake,
and formation of BNA:RNA heteroduplexes which serve as substrates for RNase
H. In addition, the chemical synthesis of these compounds is well established and
is adaptable to conventional automated synthesizers.
The protocol used for the synthesis of these compounds is detailed in Ref.
139, but will be briefly described here. Figure 28 shows the essential steps in the
synthesis of these analogues.

The starting reagents for the synthesis of

phosphorothioate DNA are hydrogen-phosphonate nucleosides (Fig. 28, structure JL),
rather than

the phosphoramidate nucleosides used in the

synthesis of

phosphodiester oligomers. These precursors are activated with an acid chloride, 1adamantanecarbonyl chloride (Fig. 28, structure 2), to yield a reactive intermediate
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F igure 27.

Effect of purified TfR antisense oligodeoxynucleotides on sTfR

expression. HL-60 cells passaged in serum-free ITS medium were exposed to the
indicated antisense oligomers at 50 uM for 24 hr. . Surface TfR levels were
assessed by direct immunofluorescence and FACS quantitation of at least 2 x IQ4
cells relative to vehicle-treated controls.
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Figure 28.

Synthesis of phosphorothioate DNA.

Scheme of single-step

sulfurization using hydrogen phosphonate chemistry. By reaction with activating
agent, 1-adamantanecarbonyl chloride (2), hydrogen phosphonate monomer (1) is
converted to (3) for coupling to solid support-bound 5’-hydroxyl groups (4). Capping
of residual hydroxyl groups and removal of the DMT protecting group (not shown)
complete one cycle of synthesis, which when repeated ultimately affords a supportbound hydrogen phosphonate backbone (5) in a full-length intermediate.

This

intermediate can be either oxidized to normal DNA (6) or sulfurized to the
phosphorothioate analogue (7). Abbreviations: A81, N6-benzoyl adenine; Gibu, N2isobutyryl guanine; CBl, N1-benzoyl cytidine; T, thymidine; Et, ethyl; DMT,
dimethoxytrityl; THF, tetrahydrofuran; Sg/CSa, elemental sulfur in carbon disulfide.

(Reprinted with permission from Elsevier Science Publishers)

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

129

C -C I
DMTO

b = a 8; G,bv c B; t

~\£j Z

RCOCI

o
0 = P-H

o-

DMT°

-

oII

^

o

®r '

0=P-H

0% rp

HNEt3

-

^

0

\
.
J
0

’*

-e y

- n

^
u/b ase
jiji

0
0 =P-H

B»»8

b -^ A j

pvnotne

£
O -f-S
o_. 0

W

0

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

B
1

K p)

130
(Fig. 28, structure 3) capable of rapid coupling to the 5’-OH of a solid supportbound nucleoside (Fig. 28, structure 4).

After the synthesis of a hydrogen-

phosphonate oligomer with the desired base sequence is completed, the
oligonucleotides, while still covalently bound at their 3’-OH ends to the solid
support, are oxidized with S8 in the presence of carbon disulfide and pyridine to
generate the intemucleotide phosphorothioate linkages (Fig. 28, structure 7). The
phosphorothioate oligomer is then cleaved from the support using ammonium
hydroxide.

Finally, in the presence of ammonium hydroxide and heat the

dimethoxytrityl and base protecting groups are removed to yield the final product.
The purification of phosphorothioate DNA is slightly more complex than
that of the phosphodiester compounds. The batch-wise sulfurization step and the
removal of the base protecting groups, which occur after the oligonucleotides are
removed from the DNA synthesizer, generate organic and inorganic salts which
may interfere with HPLC purification.

The crude oligomers, therefore, are

subjected to desalting by reverse phase liquid chromatography using Sep-Pak
cartridges prior to purification by HPLC.

Since phosphorothioates are more

hydrophobic than their phosphodiester counterparts, increased levels of acetonitrile
(24% to 30%) are required to elute these compounds from the HPLC column.

G row th Inhibition by Phosphorothioate A ntisense Oligonucleotides.
Since phosphorothioate analogues are theoretically more resistant to
enzymatic hydrolysis by serum or cellular nucleases, the biological activity of these
oligonucleotides was assessed using the parental HL-60 cell line grown in serumcontaining medium. A dose dependent inhibition of cellular growth was apparent
with all of the phosphorothioate oligomers tested. After 3 days of exposure, TTF5
exhibited the most potent biological activity.

This antisense 30-mer to the
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initiation codon region inhibited cell proliferation by 80% a t 50 uM (Fig. 29).
TTF6, a scrambled sequence congener to TTF5, also inhibited HL-60 growth, but
to a lesser degree. TTF7, a 17-mer antisense to the 5’ cap site of the TfR mRNA,
and its scrambled sequence congener, TTF8, proved far less efficacious. In fact,
slightly greater growth suppression was achieved with TTF8, a presumptive
negative control, than with TTF7, the antisense sequence. The level of growth
inhibition by all of these phosphorothioate oligonucleotides was maintained or
slightly enhanced when cell growth was assessed after 4 days of exposure (Fig.
30).
These preliminary results suggested that, unlike the phosphodiester
antisense molecules, the phosphorothioate oligomers may serve as biologically active
compounds. Although a direct investigation for an oligonucleotide length effect at
a single target site was not performed, these results suggest that oligomers longer
than 17-mers may be necessary for significant antisense-specific effects to be seen.
This finding may be related to the reduced melting temperatures of DNA:RNA
heteroduplexes consisting of phosphorothioate oligonucleotides versus those
containing phosphodiester DNA (105). Stein et al. found that melting temperatures
for oligonucleotide heteroduplexes were reduced by 15-20°C for phosphorothioates
relative to phosphodiester oligomers of equal length, with the difference diminishing
with increasing oligomer length. This observation indicated that phosphorothioate
oligomers did not hybridize to RNA as well as did unmodified oligonucleotides.
Thus, the use of longer oligomers, ie. 30-mers, may overcome this relative
thermodynamic instability to promote heteroduplex complementation in the
phosphorothioate series.
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Figure 29. Dose response of phosphorothioate oligonucleotides on HL-60 growth
(72 hr). HL-60 cells passaged in serum-containing medium were exposed to 10 uM,
25 uM, or 50 uM of the indicated oligomers. Cell growth was assayed after 72
hrs.
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Figure 30. Dose response of phosphorothioate oligonucleotides on HL-60 growth
(96 hr). HL-60 cells passaged in serum-containing medium were exposed to 10 uM,
25 uM, or 50 uM of the indicated oligomers. Cell growth was assayed alter 96
hrs.
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Surface TfR Inhibition by Phosphorothioate A ntisense O ligonucleotides.
At 50 uM, all of the sequences tested displayed varying degrees of TfR
inhibitory activity after only 24 hr of incubation (Pig. 31).

Antisense 17-mers

against the initiation codon (TTF1) and the cap site (TTF7) inhibited surface TfR
expression by 50% and 75%, respectively. However, TT1S, the sense congener to
TTF1, and TTF8, a scrambled congener of TTF7, proved to be more efficacious,
suggesting that the inhibition may not be through an antisense mechanism.
Although >90% receptor inhibition was achieved using 30-mer molecules, the
antisense (TTF4 and TTF5) and scrambled sequence (TTF6) oligomers proved
equally effective. The sTfR inhibition mediated by the oligonucleotides was not a
transient phenomenon. Levels of sTfR continued to remain suppressed through 48
hr in cells exposed to TTF5 and TTlS (Fig. 32).
Interestingly, a significant difference in the biological activity between
antisense and sense oligomers was observed only with the phosphorothioate
analogues of the c-myc 15-mer.

Surface TfR expression in cells exposed to the

antisense sequence (TMY1) were approximately five-fold lower than that of cells
treated with the sense sequence (TMYS). Although the phosphodiester congener
of the same sequence as TMY1 did not prevent the expression of TfR in mitogenstimulated lymphocytes (93), it is not surprising that we observed receptor
inhibition.

Previous studies of the c-myc antisense phosphodiester oligomer

reported growth arrest in HL-60 cells (91,92). TfR down-regulation at both the
protein and mRNA levels are well-characterized events preceding the inhibition of
proliferation in HL-60 cells (41,43,64).
Although TfR levels may decline as a consequence of cellular growth
inhibition, the oligonucleotide-mediated inhibition of surface TfR preceded growth
inhibition in HL-60 cells. Marked inhibition of surface TfR was observed after only
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Figure 31. Effect of phosphorothioate antisense DNA on sTfR expression in HL60 cells. Cells grown in serum-containing medium were exposed to the indicated
phosphorothioate oligonucleotides at 50 uM for 24 hr.

Surface TfR levels were

assessed as described in the legend to Fig. 6. Results represent the mean of at
least two experiments in which the variability of individual measurements is less
than 10% of the mean. Striped bars, 15-mers; stippled bars, 17-mers; solid bars,
30-mers.
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F igure 32. Effect of phosphorothioate antisense DNA on sTfR expression at 24
and 48 hr. Cells grown in serum-containing medium were exposed to the indicated
phosphorothioate oligonucleotides at 50 uM. Surface TfR levels were assessed at
24 and 48 hr as described in the legend to Fig. 6.
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24 hr of exposure to phosphorothioate oligonucleotides at which time there were
no significant differences in cell number. Inhibition of growth relative to control
cells became apparent only after 24 hr of treatment and was typically assessed
after 72 hr.
The degree of oligonucleotide-mediated growth inhibition generally paralleled
the level of sTfR inhibition (Fig. 33). This was seen most clearly in the series of
anti-TfR 17-mers and the anti-myc oligonucleotides.

In agreement with our

observation that HL-60 cells express more TfR than minimally required to sustain
growth (unpublished data), inhibition of surface TfR levels by less than 50% (TMYS
and TTF1) resulted in negligible effects on HL-60 cellular proliferation.
Surprisingly, although the receptor inhibitory activities between the 30-mers were
similar, the growth inhibition achieved by the antisense oligomer (TTF5) was much
greater than that of its scrambled sequence congener (TTF6). The reason(s) for
this differential is unclear.

Stability o f Phosphodiester and Phosphorothioate O ligonucleotides in Cell
Culture.
To gain insight into the mechanism responsible for the differential biological
activity

seen

between

the

antisense

phosphodiester

and

the

antisense

phosphorothioate oligonucleotides, the nuclease susceptibility of these molecules was
examined.

A 17-mer antisense molecule (TF1) was 5’-end labeled with T4

polynucleotide kinase and ^-A T P , incubated for up to 72 hr in fetal bovine serum
(FBS), in heat-inactivated FBS, and with HL-60 cells grown in heat-inactivated
FBS, and analyzed by sequencing gel electrophoresis (Fig 34). The phosphodiester
oligomer was rapidly hydrolyzed by serum nucleases to smaller sequences, resulting
in the appearance of a characteristic DNA "ladder." After only 4 hr in FBS, the
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F igure 33. Effect of phosphorothioate antisense DNA on HL-60 growth. Cells
grown in serum-containing medium were exposed to 50 uM of the indicated
phosphorothioate oligonucleotides for 3 days. Proliferation in oligomer-treated cells
is expressed relative to vehicle-treated control cultures.

Results represent the

mean ± S.D. of at least three experiments except in the cases of TMY1, TMYS,
and TTF1, which represent the mean of two experiments. Striped bars, 15-mers;
stippled bars, 17-mers; solid bars, 30-mers.
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Figure 34. Stability of phosphodiester antisense DNA in culture media.

TF1

oligonucleotide was 5’-end labeled with [“PJATP and incubated at 37°C for the
indicated periods of time in RPMI 1640 medium with 15% FBS, 15% heatinactivated (HI) FBS, or 15% HI-FBS + HL-60 cells.

Oligomer stability was

evaluated

and

by

polyacrylamide

gel

electrophoresis

autoradiography.

Oligonucleotide sizing markers are shown at right.
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undigested 17-mer was completely absent, with the majority of remaining oligomer
being in the 13- to 15-mer length range. In contrast, heat-inactivation of serum
abolished this endogenous nuclease activity and the parental 17-mer was stable
through 24 hr. The addition of proliferating HL-60 cells to medium containing
heat-inactivated serum resulted in the appearance of a nuclease activity different
from that seen in serum alone. This presumed cell-associated nuclease activity
displayed slower kinetics of hydrolysis and appeared to be an endonuclease by the
absence of a discrete DNA ladder. A 5’-phosphatase was apparently endogenous
to FBS and/or elaborated by HL-60 cells as evidenced by the temporal loss of total
“T* signal associated with oligomers.
Heat-inactivated fetal bovine sera are commercially available. To determine
whether significant differences in the levels of nuclease activities existed between
commercially supplied heat-inactivated FBS versus that prepared in the laboratory,
these were assayed in the system described above. A commercial preparation of
Hl-serum (GIBCO) was tested against a lot of serum (Sigma) treated at 65°C for
30 min. 5’-End labeled oligonucleotide (TF1) was rapidly hydrolyzed in the GIBCO
preparation as shown by the appearance of a DNA ladder after as little as 1 hr
(Fig. 35A). To a first approximation, this preparation contained similar levels of
nuclease activity as that in serum which had not been manually heat-inactivated
at all (compare with Fig. 34).

In contrast, manual heat-inactivation served to

substantially eliminate nuclease activity during the assay period as shown by the
retention of the parental oligomer band and delay in the appearance of a DNA
ladder until 12 hr (Fig. 35B). Increased hydrolysis of TFl was seen at 24 hr in
Figure 35B versus Figure 34 because the oligomer was incubated in 100% serum
in the former versus 15% serum in the latter. Clearly, not all heat-inactivated
sera are created equally, at least with respect to nuclease activity.
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Figure 35. Stability of phosphodiester antisense DNA in heat-inactivated serums.
TF1 oligonucleotide was 5’-end labeled with [^JA TP and incubated at 37°C for the
indicated periods of time in 100% serum.

Oligomer stability was evaluated by

polyacrylamide gel electrophoresis and autoradiography.

Oligonucleotide sizing

markers are shown for reference.
A: Commercially prepared heat-inactivated fetal bovine serum from GIBCO.
B: Fetal bovine serum from Sigma which had been heat-inactivated at 65°C for
30 min in the laboratory.
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In contrast, modification of the same sequence with phosphorothioate groups
at each intemucleoside linkage (TTF1) resulted in marked resistance to serum
nuclease hydrolysis (Fig. 36). No degradation in FBS was seen through 10 hr as
judged by the absence of a DNA ladder. It was unclear whether further incubation
with serum resulted in nuclease hydrolysis because a serum-derived 5-phosphatase
activity, presumably similar to that seen in Figure 34, removed the

label from

the parental oligonucleotide, resulting in a gradual attenuation of the 17-mer
signal. This interpretation was supported by the lack of non-enzymatic hydrolysis
or loss of the

label when TTF1 was incubated in ITS medium for 96 hr.

Finally, the phosphorothioates demonstrated complete resistance to cellelaborated nucleases through 48 hr of culture in serum-free medium in which
serum-derived nucleases and phosphatases were absent (Fig. 37). Interestingly,
the phosphodiester oligonucleotide, TF1, also showed absolute resistance to
hydrolysis by cell-elaborated nucleases when cultured under the same conditions
in ITS medium.

In summary, these findings suggest that markedly different

nuclease sensitivities between the phosphorothioates and the phosphodiesters may
permit biological efficacy as antisense agents in the former. In addition, it appears
possible to obviate the need for heat-inactivated serum or serum-free medium
formulations when exposing cells to phosphorothioates in culture. These results,
therefore, suggests that a primary reason for increased biological activity seen with
the phosphorothioate oligonucleotides is increased survival in tissue culture through
enhanced resistance to serum and/or cellular nucleases.

Cellular Uptake o f Phosphodiester and Phosphorothioate O ligonucleotides.
Another postulated advantage of phosphorothioate oligomers as antisense
molecules is enhanced cellular uptake owing to diminished anionic charge density
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Figure 36.

Stability of phosphorothioate oligomers in sera and ITS.

TTF1

oligonucleotide was 5’-end labeled and incubated at 37°C for the indicated intervals
in RPM I1640 medium with 15% FBS or with an insulin-transferrin-selenium (ITS)
serum-free substitute.

Oligomer stability was evaluated by polyacrylamide gel

electrophoresis and autoradiography. Oligonucleotide sizing markers are shown for
reference.
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F ig u re 37.

Stability of phosphodiester and phosphorothioate oligomers in the

presence of cells in ITS. TF1 or TTF1 was 5’*end labeled and incubated at 37°C
for the indicated intervals with HL-60 cells in RPMI 1640 medium + ITS.
Oligomer stability was evaluated by polyacrylamide gel electrophoresis and
autoradiography. Oligonucleotide sizing markers are shown at left.
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at each intemucleotide linkage. The anionic nature of the phosphodiester bond
has been theorized to inhibit oligonucleotide uptake through the hydrophobic cell
membrane (103).

Whether this is actually the case is still in question as

quantitative comparisons between the uptake of different classes of antisense
oligonucleotides possessing identical sequences have not been reported. For this
reason, we attempted to compare the cellular uptake of a phosphodiester
oligonucleotide (T1S) with its phosphorothioate congener (TT1S).
In order to perform quantitatively relevant comparisons of oligonucleotide
uptake into whole cells, 5’-end labeled oligomers must first be separated from any
unincorporated S2P-ATP in the reaction mixture such that the specific activity of
the preparations may be determined.

Sep-Pak reverse phase cartridges were

employed as a convenient method to accomplish this level of purification.

In

agreement with the unpublished observations of G. Zon, the 5’-OH from
phosphodiester oligomers served as a more efficient substrate for T4 polynucleotide
kinase than that from phosphorothioate oligomers. More of the radiolabel became
incorporated with unmodified oligonucleotide than with the phosphorothioate
counterpart (Fig. 38). The specific activity of ^-labeled T1S was four times that
of ^ -labeled TT1S.
Initial experiments focused on the association of radiolabeled oligomer with
HL-60 cells under physiological conditions. The use of cells grown in serum-free
ITS medium obviated the necessity to correct for any extracellular 5’-phosphatase
or serum derived-nuclease activities which may degenerate the radiolabeled
parental oligomer and, thereby, complicate the analysis of uptake kinetics. After
incubation with oligomer for varying periods of time, cells were layered over chilled
oil and centrifuged.

The residual aqueous and oil layers were removed by

aspiration, and the cell pellets quantified for cell-associated

signal. It must be
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F igure 38. Purification of 5’-end labeled oligonucleotides. Two nmoles of oligomer
(T1S or TT1S) were 5’-end labeled with 3 U of T4 polynucleotide kinase and 66
pmoles of “T-gamma ATP (200 uCi) at 37°C for 90 min. After boiling for 5 min,
samples were suspended into 0.2 ml of 10 mM NH4OAc. Sep-Pak cartridges were
pre-equilibrated with acetonitrile (ACN), followed by 10 mM NH4OAc. Samples
were loaded onto the columns, followed by flushing of columns with 7 ml of 10 mM
NH4OAc and 5 ml of air. Samples were eluted with 3 ml of 25% ACN in water
(T1S) or 75% ACN in water (TT1S). Finally, columns were washed with 1 ml of
100% ACN. Column fractions of 1 ml each were collected and the radioactivity
quantitated by liquid scintillation spectrometry. Abbreviations: FT, flow-through;
W, wash; E, elution.
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emphasized that this represents an overestimate of cellular uptake, as one cannot
differentiate between oligonucleotides that are loosely associated with the cell
membrane versus those than are actually within the cytoplasm and/or nucleus.
With these qualifications in mind, the characteristics of cell-association of the
phosphorothioate oligomer, TT1S, showed saturable kinetics through 2 hr (Fig. 39).
In order to determine the fraction of total cell-associated oligomer that had
been internalized, cells were additionally washed with either 0.2 M glycine or 0.2
M acetic acid and 0.5 M NaCl (140). This step removes macromolecules loosely
associated with the external face of the plasma membrane, but does not affect
internalized ligands. Cells that had been add-washed contained approximately 6fold lower levels of TT1S than untreated cells (Fig. 40). This suggested that a
significant fraction of oligonucleotides remained at or near the extracellular face
of the plasma membrane. The rapid and saturable nature of uptake kinetics was,
however, unchanged by acid-washing. Apparent maximal levels of phosphorothioate
oligonucleotide uptake were achieved after only 1 hr.

It remained possible,

however, that the presence of intracellular 5’-phosphatases may have lowered the
specific activity of internalized oligomers such that these results represented
underestimates of the actual cellular accumulation.
The uptake of TT1S, a phosphorothioate oligomer, was dramatically different
from that seen with T1S, its phosphodiester congener.

Phosphorothioate DNA

exhibited rapid and saturable uptake kinetics, with plateau levels being observed
after approximately 60 min of incubation (Fig. 41). In contrast, the same sequence
in the phosphodiester series exhibited extremely slow, essentially linear uptake
through 6 hr after which total oligonucleotide uptake was 40-fold less than that
seen with the phosphorothioate.
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F igure 39. Cell-association of phosphorothioate DNA. 5’-End labeled TT1S was
incubated at 37°C with HL-60 cells in R PM I1640 medium + ITS. At the indicated
times, cells were collected, layered over chilled oil, and centrifuged. Radioactivity
associated with the cell pellets was immediately assessed by liquid scintillation
spectrometry. Values represent the mean * S.D of 3 separate experiments.
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Figure 40. Cellular uptake of phosphorothioate DNA. 5’-End labeled TT1S was
incubated at 37°C with HL-60 cells in RPMI 1640 medium + ITS. At the indicated
times, cells were collected, layered over chilled oil and centrifuged.

After the

aqueous and oil layers were removed by aspiration, radioactivity associated with
the cell pellets was immediately assessed by liquid scintillation spectrometry and
after a 5 min acid wash at 4°C. Cell-associated radioactivity remaining after acidwashing was considered to represent internalized oligonucleotides.

Values

represent the mean ± S.D of triplicate samples.
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Figure 41. Cellular uptake of phosphorothioate vs. phosphodiester DNA. 5’-End
labeled oligonucleotides (T1S or TT1S) were incubated at 37°C with HL-60 cells in
RPMI 1640 medium + ITS. At the indicated times, cells were collected, layered
over chilled oil and centrifuged. After the aqueous and oil layers were removed
by aspiration, radioactivity associated with the cell pellets was immediately
assessed by liquid scintillation spectrometry and after a 5 min acid wash at 4°C.
Cell-associated radioactivity remaining after acid-washing was considered to
represent internalized oligonucleotides. ®, TT1S; □ , T1S. Dotted lines represent
samples not acid washed; solid lines represent acid-washed samples.

Values

represent the mean ± S.D of triplicate samples.
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Oligonucleotide uptake into eukaryotic cells is difficult to evaluate given the
limitations of experimental techniques.

Studies involving oligonucleotides

containing covalently-linked fluorescent probes, ie. acridine, suffer from the
possibility that the cellular uptake and dispersion of derivatized oligonucleotide
may be artifactually altered by the fluorescent moiety.

For this reason, our

experiments were conducted with radiolabeled oligonucleotides.

However, the

conclusions drawn from these experiments are predicated upon the assumption that
the 32P signal remaining after acid-washing of cells represents intact parental
oligonucleotide. Although the phosphorothioate TTFl was shown to be resistant
to degradation by nucleases secreted from HL-60 cells (see Fig. 37), it is within the
realm of speculation that phosphorothioate DNA is sensitive nucleases contained
within the cell. Hence, the resultant internalized

signal may not represent

oligonucleotide which is biologically active as an antisense agent.
It is also conceivable that the removal of the S2P label from oligonucleotides
by intracellular phosphatases may have resulted in an underestimate of the
amount of oligomers accumulated. The complicating effects of any serum-derived
phosphatases have, however, been eliminated in our experiments through the use
of serum-free medium.

Ideally, it would be preferable to measure the cellular

uptake of the intact parental oligonucleotide.

This could be performed by

evaluating for the presence of the intact parental oligonucleotide in whole cell
lysates by denaturing polyacrylamide gel electrophoresis.

Nevertheless, these

results represent the first attempt at quantitative comparison of the cellular
accumulation of identical antisense oligomers of the phosphodiester and
phosphorothioate series and confirm the theoretical advantage in cellular uptake
ascribed to the decreased polarity of the phosphorothioate bond.
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The enhanced cellular uptake of the phosphorothioate oligonucleotides may,
therefore, represent a second reason for the increased biological efficacy of these
compounds over the phosphodiester oligomers as antisense inhibitors.
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DISCUSSION

These experiments have characterized the biosynthetic regulation of the
transferrin receptor in chemically differentiating HL-60 leukemia cells and have
demonstrated that sTfR can be modulated using antisense phosphorothioate
oligodeoxynucleotides (63,64,148).

Using dot blot analyses, we showed that

exposure of HL-60 cells to DMSO induced a specific decrease in TfR mRNA within
the first 24 hrs and that this effect preceded both the down-regulation of surface
receptors and decreased cell proliferation as well as the appearance of the mature
phenotype (63).

We then corroborated this phenomenon using northern blot

analysis, which permitted molecular size verification that hybridized mRNAs
represented the transcripts of interest and that contaminating species contributed
little to the overall signal (64). The kinetics of the BMSO-induced decrease in TfR
message, as assessed by either dot blot or northern blot techniques, were similar
after 12 hrs of treatment, with a 50% reduction in receptor message seen.

A

comparison of the kinetics of sTfR protein and transcript levels, along with our
demonstration that DMSO did not induce a reduction in the half-life of the mature
sTfR protein, provide compelling evidence that the down-regulation of TfR during
the DMSO-induced differentiation of HL-60 cells is mediated at the mRNA level.
Confirming our initial studies, transcriptional down-regulation of the TfR gene
during chemically-induced differentiation was demonstrated by other groups (65,66)
using the technique of nuclear run-off studies in HL-60 cells.
We have also demonstrated that a reduction in steady-state TfR mRNA is
a feature common to the chemical induction of HL-60 cell differentiation by a
variety of structurally dissimilar agents.

The reduction in TfR mRNA did not

appear to be secondarily related to decreased nuclear transcriptional activity, since
167

R e p r o d u c e d with p e r m i s s io n of th e co p y rig h t o w n er. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

168

appreciable changes in *H-uridine incorporation and in the steady-state levels of
fi-actin transcripts or ribosomal KNA did not occur during the first 24 hrs of
exposure to inducers.

This effect on the TfR was not a metabolic consequence

specific to the action of DMSO, since other myeloid inducers with disparate
intracellular actions, including ACM and RA, caused similar reductions.
Furthermore, the biosynthetic modulation of the TfR was not restricted to a
particular cell lineage, since HL-60 cells induced to differentiate along the
macrophagic pathway hy TPA also demonstrated decreased receptor transcripts.
Taken together, these observations suggest that down-regulation of TfR transcripts
is a fundamental feature in the chemical induction of HL-60 cell differentiation.
In addition, TfR expression appears to be an important general process in
the differentiation of leukemic cells, as receptor down-regulation was also observed
with the Ml and K562 leukemias (46,47).

In contrast to these effects, Friend

erythroleukemia cells have been shown to express 3- and 6*fold increases in
cellular TfR after 3 and 5 days, respectively, of DMSQ-induced erythroid
differentiation (48). This difference in TfR metabolism between myeloid leukemia
and erythroleukemia cells appears to be due to the increased biochemical
requirement for iron in the synthesis of hemoglobin in mature reticulocytes. In
addition, cellular enucleation serves as a distinct mechanism for terminating
replication in erythroid differentiation.

Thus, the increase in transferrin-TfR

activity in Friend erythroleukemia cells is obligatory for the expression of the
mature erythroid phenotype.
Terminal differentiation, by definition, involves both the programmed
cessation of proliferation and the acquisition of a mature phenotype.
relationship of these two pathways remains to be determined.

The

Since TfR

expression is enhanced by the stimulation of cellular proliferation in other systems
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(45), reductions in TfR mRNA and protein biosynthesis may be viewed as a
consequence of growth inhibition and, therefore, be unrelated to differentiation per
se. Indeed, untreated HL-60 cells in plateau phase growth exhibited pronounced
reductions in sTfH to levels analogous to those seen with terminally differentiated
cells. The kinetics of TfR down-regulation in differentiating cells, however, differs
markedly, depending upon the inducer employed.

Nevertheless, a significant

temporal relationship exists between the degree of surface receptor down-regulation
and the eventual inhibition of growth.

Thus, we have observed a complete

cessation of cellular proliferation within 10 to 16 hrs after induced cells expressed
a four-fold decrease in sTfR. Cells induced to mature with la,25-dihydroxyvitamin
D3, however, did not down-regulate sTfR to this degree. Accordingly, these cells
expressed no growth inhibition relative to uninduced cells.
Corroborating evidence for this hypothesis was provided by experiments with
exogenous iron or the iron chelator, deferrioxamine. Attempts to manipulate iron
availability in parallel or in opposition to that resulting from TfR down-regulation
resulted in alterations to cellular proliferation, without attendent effects on cellular
maturation. Modulation of TfR activity is clearly not a simple consequence of the
termination of growth, since down-regulation was always seen prior to the cessation
of proliferation and the appearance of significant alterations in the cell cycle
profiles of induced cells. Thus, these findings suggest that TfR down-regulation
may be involved in signalling a programmed inhibition of growth which is requisite
for terminal differentiation.
It is intriguing that a conflicting trend exists between sTfR and intracellular
transcript levels during the initial 12 hrs of TPA induction.

We interpret the

maintenance of unchanged levels of total cellular TfR reported by others (50)
concommitant with the increasing amounts of TfR message which we observe in
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TPA-treated cells (64) to suggest another potential mode of regulation in the
biosynthesis of this receptor. The findings suggest that normal regulation of TfR
biosynthesis is uncoupled, whereby newly synthesized transcripts are not
translated.

Conceivably, phorbol esters may induce modulations in the cellular

translational apparatus which reduce recognition of TfR transcripts. Alternatively,
intrinsic alterations in the mRNA, such as additions, deletions, or splicing, which
do not appreciably change message size and, hence, are undetectable by probe
hybridization cannot be excluded.

Future experiments should investigate the

molecular mechanism(s) behind this newly observed phenomenon.
The mechanisms by which the differentiation inducers, TPA and ACM,
modulate sTfR levels in HL-60 cells have been previously demonstrated to involve
protein phosphorylation and glycosylation, respectively. The phorbol esters alter
the cellular distribution of the receptor by promoting a rapid (tV6=60 min)
internalization of membrane associated TfR, a phenomenon correlated with
phosphorylation of the protein at serine residues by protein kinase C (50,52). The
anthracyclines, ACM and marcellomycin, appear to reduce transferrin binding by
inhibiting glycosylation during the biosynthesis of the receptor (49).

We now

demonstrate that TPA and ACM act via an additional mechanism to decrease
steady-state levels of TfR message.
Our results are consistent with the hypothesis that a down-regulation of the
sTfR mediates the cessation of proliferation in differentiating HL-60 cells. This
may be partly due to a reduction in TfR transcription during granulocytic
differentiation.

Surface TfR internalization is rapidly promoted during TPA-

induced monocytic differentiation, hence an increase in transcript levels does not
significantly influence the initial decrease in receptor activity. Whether this is a
feature of monocytic differentiation or a specific consequence of the stimulation of
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protein kinase C by TPA is unresolved. However, a drastic decline in the level of
steady-state message does contribute to the maintenance of diminished TfR in cells
differentiated by TPA.
The process of terminal differentiation is complex, with a multitude of
requisite cellular alterations occurring with differing kinetics.

In addition, the

diversity of agents capable of inducing differentiation implies th at numerous
intracellular targets exist which may transmit the initiating signal(s). Ultimately,
alterations in nuclear activity must occur in order to commit cells to a
differentiation pathway and to maintain the mature phenotype. The TfR appears
to be an important component of the genetic changes underlying leukemic cell
differentiation; however, its precise role within this framework of cellular mediators
and processes critical to the maturation process remains to be fully elucidated.
One potential strategy to probe the role of TfR in leukemia cell
differentiation involves the use of more specific agents which, ideally, modulate the
cellular homeostasis of TfR, but lack disparate biochemical activities within the
cell. Antisense oligodeoxynucleotides have emerged as novel and specific inhibitors
of gene expression, thus seem uniquely suited for this purpose. This field was
pioneered by the work of Zamecnik and Stephenson (74,75) who, in 1978, described
the inhibition of Rous sarcoma virus replication by a tridecamer (13-mer)
complementary to terminal repeat sequences of the viral 35S RNA. Since then,
this strategy has been applied in a variety of eukaryotic and viral systems against
disparate cellular targets, including z-myc (91-94), c-myb (95-97), c-mos (149), Bglobin (107), cyclin (98), dihyrofolate reductase (99), herpes simplex virus type 1
(114,118), and human immunodeficiency virus (HIV) type 1 (112,113,116-120,150).
The early studies with antisense DNA were limited to first generation
oligodeoxynucleotides possessing internucleoside phosphodiester linkages similar to
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that of native DNA. HL-60, a human promyelocytic leukemia cell line, has served
as a convenient model system for many of the early antisense studies. Wickstrom
et al. (91) employed a pentadecamer (15-mer) complementary to the initiation codon
region of the c-myc oncogene; at 10 uM, this oligomer inhibited myc protein
expression as detected by both immunofluorescence and by immunoprecipitation.
Furthermore, cell proliferation was inhibited in a dose-dependent and sequencespecific manner, and antisense pentadecamers to the vesicular stomatitis virus
(VSV) and to the HIV tat gene were without effect on myc expression. Further
work by this group demonstrated that this anti-myc 15-mer induced NBT activity,
morphological maturation consistent with granulocytic differentiation, and reduced
colony formation in soft agar (151).

Using the same system, Holt et al. (92)

similarly demonstrated that the anti-myc oligonucleotide induced granulocytic
differentiation in approximately 30% of cells after 3 days of treatment.

These

results, however, contrasted with previous reports in which antisense RNA to myc
induced monocytic differentiation (88).
We have demonstrated that phosphorothioate antisense oligonucleotides are
more efficacious than their phosphodiester counterparts as inhibitors of TfR
expression in HL-60 leukemia cells.

The degree of receptor suppression was

dependent upon oligomer length with 30-mer compounds uniformly displaying
greater activity than 17-mers.

However, the effects seen with the anti-TfR

oligonucleotides could not be fully ascribed to antisense mechanisms, since sense
oligomers and those in which the base sequence was partially scrambled
consistently showed equivalent or greater activity than their antisense counterparts.
In general, the degree of oligonucleotide-mediated growth inhibition was
proportional to the decrease in receptor levels. An interesting exception occurred
with the antisense 30-mer, TTF5, and its scrambled sequence congener, TTF6.
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Whereas both inhibited sTfR expression to a similar degree, the antisense sequence
TTF5 was nearly twice as efficacious as TTF6 in suppressing cellular growth.
The reason(s) underlying this observation remains to be determined.
However, that TTF5 and TTF6 are 30-mers may have significance. Heteroduplexes
formed between polyribonucleotides and phosphorothioate oligomers have melting
temperatures approximately 15-20°C lower relative to those formed using
phosphodiester oligomers of equal length (105). This difference diminished with
increasing oligonucleotide length.

This relative thermodynamic instability of

complementation results in the theoretical need to employ longer sequences to
achieve similar levels of heteroduplex formation as that accomplished by shorter
sequences of phosphodiester oligonucleotides. Interestingly, a heteroduplex of polytA and a phosphorothioate dT-homooligomer of 28 bases had a melting temperature

of 36°C (105). Thus, the phosphorothioate 30-mers, in contrast with the 17-mers,
may be of a sufficient length to bind by an antisense mechanism to TfR mRNA at
physiological temperatures, thereby permitting distinction between the biological
activities of antisense versus sense or missense sequences.
A high concentration (50 uM) of oligonucleotides was selected for use during
these in-vitro studies.

It is conceivable that elevated concentrations of

phosphorothioate oligonucleotides have "toxic", ie. antisense-independent, effects on
cellular targets. At lower concentrations, the antisense effects predominate and
biological activity would correlate with sequence specificity.

At higher

concentrations, however, antisense-independent activities, which have not been fully
characterized, may emerge.

This titration between predicted and unpredicated

cellular activities may result in the appearance of a sequence-independent
phenomenon. Hence, our inability to demonstrate an antisense-specific suppression
of sTfR by phosphorothioate oligonucleotides may also be explained if receptor
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inhibition is a manifestation of toxicity by these compounds. Since the antisense
sequence TTF5 inhibits cellular growth better than its scrambled sequence congener
TTF6, this suggests that antisense mechanisms are operative, as least in part.
The evaluation of these oligonucleotides at lower concentrations, where these
sequence-independent toxicities are less prevalent, may help to verify this
hypothesis.
Antisense mediated TfR and growth inhibition also occurred using an antimyc phosphorothioate 15-mer.

Since enhanced c-myc expression is related to

increased cellular proliferation, it is not surprising that inhibition of c-myc led to
interference with growth and the expression of TfR. It is a reasonable postulate
that the anti-myc phosphorothioate oligomer may not act directly to inhibit the
expression of the TfR gene. Rather, the presumed inhibition of c-myc expression
in these cells may result in the propagation of intracellular signals which act to
suppress proliferation. This, in turn, would result in a decreast in sTfR activity
since non-replicating cells have reduced iron uptake requirements.
The precise mechanism(s) by which phosphorothioate oligonucleotides exert
gene inhibitory activity within the cell remains unclear. Consistent with classical
antisense theory, the phosphorothioates have been shown to bind to single-strand
RNA, forming heteroduplexes which may Berve as substrates for RNase H
degradation

(107,121).

However,

sequence-independent

actions

of

the

phosphorothioate oligonucleotides are pleiotropic and have been well documented.
For example, Matsukura et al. (117) showed that a 28-mer phosphorothioate
oligodeoxycytidine homooligomer (S-dC^) inhibited the cytopathic effect of HIV by
direct interference with the retroviral reverse transcriptase.

Interestingly, in

agreement with our results, phosphorothioate inhibition of HIV activity was
dependent upon length, with 28-mers being more potent than 14-mers; 5-mers
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showed no activity. In an analogous manner, S-dC^ was found to be a competitive
inhibitor of HSV type 2 DNA polymerase, but interfered with human DNA
polymerases less effectively (118). Finally, the inhibition of HIV replication by
cholesteryl-conjugated oligonucleotides did not correlate with a specific antisense
sequence, suggesting an action other than an antisense mechanism may be
operative (152).

Our findings support the concept th at phosphorothioate

oligonucleotides may express biological activities independent of conventional
antisense gene inhibition.
We have demonstrated that the enhanced nuclease resistance and cellular
uptake ascribed to the phosphorothioate oligonucleotides may be involved in their
increased biological efficacy over their phosphodiester counterparts. Others have
previously described this phenomenon using purified enzymes (105,153) and serum
(147). Stein et al. found that phosphorothioate oligomers were more resistant to
hydrolysis by endonuclease SI, the exo- and endonuclease P I, and snake venom
phosphodiesterase by 40-fold, 20-fold, and 2000-fold, respectively (105). Spitzer and
Eckstein determined that phosphorothioate oligomers were more resistant to
hydrolysis by staphylococcal nuclease and spleen phosphodiesterase by 10-fold and
100-fold, respectively; the phosphorothioate oligonucleotides were completely
resistant to degradation by pancreatic DNase I and spleen DNase II (153). We
have extended these observations by directly comparing biological activity with
serum and cellular nuclease susceptibility using identical sequence oligomers of the
phosphodiester (TF1) and phosphorothioate (TTF1) series.
For biological activity to be expressed, antisense oligonucleotides must
traverse the plasma membrane of cells. The mechanism by which cells accumulate
oligomers from the extracellular environment is still unclear.

Loke et al.

determined that the cellular uptake of antisense DNA is a saturable and size-
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dependent

process

compatible

with

receptor-mediated

endocytosis

(154).

Furthermore, by using oligo-dT cellulose for affinity purification, this group
identified an 80 kD surface protein from HL-60 cells which may mediate this
transport process.

Similarly, Yakubov et al. found that 69 kD and 90 kD

membrane proteins from mouse fibroblasts could be cross-linked to radiolabeled
phosphodiester oligonucleotides (155). That the uptake of phosphodiester oligomers
by this mechanism was competed by phosphorothioates suggests that these two
classes of oligonucleotides may share this uptake mechanism (154). Our finding
of rapid and saturable uptake kinetics is consistent with this model for cellular
uptake. Furthermore, our results represent the first quantitative comparison of the
cellular accumulation of identical antisen3e oligomers of the phosphodiester and the
phosphorothioate series and confirm the theoretical advantage in cellular uptake
ascribed to the decreased polarity of the phosphorothioate bond.
In summary, phosphorothioate oligonucleotides were uniformly more
efficacious than their unmodified phosphodiester counterparts as inhibitors of TfR
expression and proliferation in HL-60 cells in culture.

A greater resistance to

hydrolysis by serum and cellular nucleases and more efficacious cellular uptake of
the phosphorothioate analogues in comparison to their phosphodiester counterparts
appeared to contribute to their greater biological activity. The means of inhibition
of gene expression by the phosphorothioates in this eukaryotic system may,
however, involve pleiotropic mechanisms independent of antisense complementary
binding to mRNA. Thus, the findings support recent reports that the antiviral
activity of phosphorothioate oligonucleotides may involve other cellular targets in
addition to viral transcripts. Further efforts to delineate the intracellular actions
of the phosphorothioates will be required before the therapeutic potential of these
compounds as antitumor or antiviral agents can be fully assessed.
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CONCLUSIONS

1.

Transferrin

receptor down-regulation which occurs during granulocytic

differentiation by dimethyl sulfoxide, retinoic acid, or aclacinomycin A
appears to be kinetically compatible with reduced biosynthesis resulting from
reductions in the level of steady state mRNA (Figures 7,9-11; Tables 3,4).

2.

In contrast, biosynthetic modulation does not appear to mediate the initial
receptor

down-regulation

differentiation.

seen

during

TPA-induced

macrophagic

However, a reduction in the levels of receptor mRNA

appears to contribute to the maintenance of diminished TfR activity in these
TPA-treated cells (Figures 7,9; Table 3).

3.

The kinetics of sTfR down-regulation in differentiating cells differs markedly
depending upon the inducer used.

Nevertheless, a significant temporal

relationship exists between the degree of receptor down-regulation and the
eventual inhibition of growth (Figures 3,7,12,14). A complete cessation of
cellular proliferation is observed within 10 to 16 h after induced cells
expressed a 4-fold reduction in sTfR (Table 2).

Additionally, the

manipulation of extracellular iron levels markedly modulated the cellular
growth of uninduced and induced cells without attendent effects on cellular
maturation, either alone or in concert with DMSO or RA (Figures 17,18).
These findings suggest that TfR down-regulation may be involved in the
signaling a programmed inhibition of growth which is requisite for terminal
differentiation.
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4.

Phosphorothioate anti-TfR antisense oligonucleotides exhibited marked
biological efficacy in culture, as assessed by inhibition of surface TfR content
and HL-60 growth, whereas their unmodified phosphodiester counterparts
were ineffective (Figures 27, 29-33).

5.

A length effect was observed, with antisense 30-mers exhibiting greater TfR
inhibitory activity than 17-mers (Figures 31,33). The degree of receptor
inhibition observed, however, was not strictly sequence dependent, suggesting
that the phosphorothioate oligonucleotides may have pleiotropic activities in
eukaryotic cells in addition to inhibiting gene expression by presumptive
antisense complementary binding to mRNA.

6.

Phosphorothioate oligonucleotides were more resistant to hydrolysis by serum
and cellular nucleases (Figures 34,36,37), and were more readily taken up
by cells than phosphodiester oligonucleotides (Figures 41), thus providing a
partial explanation for the differences in biological activity.

R e p r o d u c e d with p e r m i s s io n of t h e co p y rig h t o w n er. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

179
REFERENCES
1. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth and
differentiation of human myeloid leukemia cells in suspension culture. Nature,
270:347-349, 1977.
2. Dalton, W. T., Aheam, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A.,
and Trujillo, J. M. HL-60 cell line was derived from a patient with FAB-M2 and
not FAB-M3. Blood, 71:242-247, 1988.
3. Collins, S. J. The HL-60 promyelocytic leukemia cell line: proliferation,
differentiation, and cellular oncogene expression. Blood, 70:1233-1244, 1987.
4. Bimie, G. D. The HL-60 cell line: a model system for studying human
myeloid cell differentiation. Br. J. Cancer, 58, Suppl. DC:41-45, 1988.
5. Collins, S. J., and Groudine, M. Amplification of endogenous myc-related DNA
sequences in a human myeloid leukaemia cell line. Nature, 298:679-681, 1982.
6. Graham, S. V., Tindle, R. W., and Bimie, G. D. Variation in myc gene
amplification and expression in sublines of HL60 cells. Leuk. Res., 9:239-247,
1985.
7. Huebner, K., Isobe, M., Croce, C. M., Golde, D. W., Kaufman, S. E., and
Gasson, J. C. The human gene encoding GM-CSF is at 5q21-q23, the chromosome
region deleted in the 5q- anomaly. Science, 230:1282-1285, 1985.
8. Bos, J., Verlaan-De Vries, M., Jansen, A., Veeneman, G. H., van Boom, J. H.,
and van der Eb, A. J. Three different mutations in codon 61 of the human Nras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res.,
12:9155-9163, 1984.
9. Hickman, J. A., and Friedman, R. M. Pharmacology and mechanisms of action
of differentiation agents, in The Status of Differentiation Therapy of Cancer. S.
Waxman, G. B. Rossi, F. Takaku (eds.). Raven Press, NY. Vol. 45, pp. 231-252,
1988.
10. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., Gallo, R. C. Terminal
differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide
and other polar compounds. Proc. Natl. Acad. Sci. USA, 75:2458-2462, 1978.
11. Spremulli, E. N., and Dexter, D. L. Polar solvents:
antineoplastic agents. J. Clin. Oncol., 2:227-241, 1984.

a novel class of

12. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation
of human promyelocytic leukemia cells (HL-60) by retinoic arid. Proc. Natl. Acad.
Sri. USA, 77:2936-2940, 1980.

R e p r o d u c e d with p e r m i s s io n of t h e co p y rig h t o w n er. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

180
13. Collins, S. J., Bodner, A., Ting, R., and Gallo, R. C.
Induction of
morphological and functional differentiation of human promyelocytic leukemia cells
(HL-60) by compounds which induce differentiation of murine leukemia cells. Int.
J. Cancer, 25:213-218, 1980.
14. Bodner, A., Ting, R. C., and Gallo, R. C. Induction of differentiation of human
promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl.
Cancer Inst., 67:1025-1030, 1981.
15. Schwartz, E. L., and Sartorelli, A. C. Structure-activity relationships for the
induction of differentiation of HL-60 human acute promyelocytic leukemia cells by
anthracyclines. Cancer Res., 42:2651-2655, 1982.
16. Rovera, G., Santoli, D., and Damsky, C. Human promyelocytic leukemia cells
in culture differentiate into macrophage-like cells when treated with a phorbol
diester. Proc. Natl. Acad. Sci. USA, 76:2779-2783, 1979.
17. Abrahm, J., and Rovera G. The effect of tumor-promoting phorbol diesters on
terminal differentiation of cells in culture. Molec. Cell. Biochem., 31:165-175,1980.
18. Miyaura, C., Abe, E., Kuribayashi, T., Tanaka, H., Konno, K., Nishii, Y., and
Suda, T. la,25-Dihydroxyvitamin D3 induces differentiation of human myeloid
leukemia cells. Biochem. Biophys. Res. Commun., 102:937-943, 1981.
19. Sundstrom, C., and Nilsson, K. Establishment and characterization of a
human histiocytic lymphoma cell line (U-937). Int. J. Cancer, 7:565-577, 1976.
20. Lozzio, C. B., and Lozzio, B. B. Human chronic myelogenous leukemia cellline with positive Philadelphia chromosome. Blood, 45:321-334, 1975.
21. Friend, C., Scher, W., Holland, J. G., and Sato, T. Hemoglobin synthesis in
murine virus-induced leukemic cells in vitro:
stimulation of erythroid
differentiation by dimethylsulfoxide. Proc. Natl. Acad. Sci. USA, 68:378-382,1971.
22. Warner, N. L., Moore, M. A. S., and Metcalf, D.
A transplantable
myelomonocytic leukemia in BALB/c mice: cytology, karyotype, and muramidase
content. J. Natl. Cancer Inst., 43:963-982, 1969.
23. Ichikawa, Y. Differentiation of a cell line of myeloid leukemia.
Physiol., 74:223-234, 1969.

J. Cell.

24. Reiss, M., Gamba-Vitalo, C., and Sartorelli, A. C. Induction ct tumor cell
differentiation as a therapeutic approach: preclinical models for hematopoietic and
solid neoplasms. Cancer Treatment Reports, 70:201-218, 1986.
25. Schwartz, E. L., and Wieraik, P. H. Differentiation of leukemia cells by
chemotherapeutic agents. J. Clin. Pharmacol., 28:779-794, 1988.
26. Dexter, T. M., and Spooncer, E. Growth and differentiation in the hemopoietic
system. Ann. Rev. Cell Biol., 3:423-441, 1S87.

R e p r o d u c e d with p e r m i s s io n of t h e co p y rig h t o w n e r. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

181
27. Sachs, L. The molecular control of blood cell development. Science, 238:13741379, 1987.
28. Barnes, D., and Sato, G. Serum- free cell culture: a unifying approach. Cell,
22:649-655, 1980.
29. Hemmaplardh, D., and Morgan, E. H. Transferrin and iron uptake by human
cells in culture. Exp. Cell Res., 87:207-212, 1974.
30. Trowbridge, I. S., Newman, R. A., Domingo, D. L., and Sauvage, C.
Transferrin receptors: structure and function. Biochem. Pharmacol., 33:925-932,
1984.
31. May, W. S., and Cuatrecasas, P.
Transferrin receptor: its biological
significance. J. Membr. Biol., 88:205-215, 1985.
32. Schneider, C., Sutherland, R., Newman, R. A., and Greaves, M. F. Structural
features of the cell surface receptor for transferrin that is recognized by the
monoclonal antibody OKT9. J. Biol. Chem., 257:8516-8522, 1982.
33. Van Driel, I. R., and Coding, J. W. Heterogenous glycosylation of murine
transferrin receptor subunits. Eur. J. Biochem., 149:543-548, 1985.
34. Omary, M. B., and Trowbridge, I. S. Covalent attachment of fatty acid to
the transferrin receptor in cultured human cells. J. Biol. Chem., 256:4715-4718,
1981.
35. Omary, M. B., and Trowbridge, I. S. Biosynthesis of the human transferrin
receptor in cultured cells. J. Biol. Chem, 256:12888-12892, 1981.
36. Hopkins, C. R. Intracellular routing of transferrin and transferrin receptors
in epidermoid carcinoma A431 cells. Cell, 35:321-330, 1983.
37. Willingham, M. C., Hanover, J. A., Dickson, R. B., and Pastan I.
Morphological characterization of the pathway of transferrin endocytosis and
recycling in human KB cells. Proc. Natl. Acad. Sci. USA, 81:175-179, 1984.
38. Ward, J. H., Kushner, J. P., and Kaplan, J. Regulation of HeLa cell
transferrin receptor. J. Biol. Chem., 257:10317-10323, 1982.
39. Mattia, E., Rao, K , Shapiro, D. S., Sussman, H. H., and Klausner, R. D.
Biosynthetic regulation of the human transferrin receptor by desferrioxamine in
K562 cells. J. Biol. Chem., 259:2689-2692, 1984.
40. Testa, E. P., Testa, U., Samoggia, P., Salvo, G., Camagna, A., Peschle, C.
Expression of transferrin receptors in human erythroleukemic lines: regulation in
the plateau and exponential phases of growth. Cancer Res., 46:5330-5334, 1986.
41. Omary, M. B., Trowbridge, I. S., and Minowada, J. Human cell-surface
glycoprotein with unusual properties. Nature, 286:888-891, 1980.

R e p r o d u c e d with p e r m i s s io n of t h e co p y rig h t o w n er. F u r th e r r e p r o d u c tio n prohibited w ith o u t p e r m is s io n .

182

42. Trowbridge, I. S., and Omary, M. B. Human cell surface glycoprotein related
to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. USA,
78:3039-3043, 1981.
43. Sutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J., and
Greaves, M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferationassociated receptor for transferrin. Proc. Natl. Acad. Sci. USA, 78:4515-4519,1981.
44. Trowbridge, I. S., and Lopez, F. Monoclonal antibody to transferrin receptor
blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc.
Natl. Acad. Sci. USA, 79:1175-1179, 1982.
45. Neckers, L. M., and Cossman, J. Transferrin receptor induction in mitogenstimulated human T lymphocytes is required for DNA synthesis and cell division
and is regulated by interleukin 2. Pioc. Natl. Acad. Sci. USA, 80:3494-3498, 1983.
46. Testa, U., Thomopoulos, P., Vinci, G., Titeux, M., Bettaieb, A., Vainchenker,
W., and Rochant, H. Transferrin binding to K562 cell line. Exp. Cell Res.,
140:251-260, 1982.
47. Tei, I., Makino, Y., Sakagami, H., Kanamaru, I., and Konno, K. Decrease of
transferrin receptor during mouse myeloid (Ml) cell differentiation. Biochem.
Biophys. Res. Common., 107:1419-1424, 1982.
48. Hu, H. Y., Gardner, J., and Aisen, P. Inducibility of transferrin receptors on
Friend erythroleukemia cells. Science, 197:559-561, 1977.
49. Morin, M. J., and Sartorelli, A. C. Inhibition of glycoprotein biosynthesis by
the inducers of HL-60 cell differentiation, acladnomydn A, and marcellomycin.
Cancer Res., 44:2807-2812, 1984.
50. May, W. S., Jacobs, S., Cuatrecasas, P. Assodation of phorbol ester-induced,
hyperphosphoiylation and reversible regulation of transferrin membrane receptors
in HL60 cells. Proc. Natl. Acad. Sd. USA, 81:2016-2020, 1984.
51. May, W. S., Sahyoun, N., Jacobs, S., Wolfe, M., and Cuatrecasas, P.
Mechanism of phorbol diester-induced regulation of surface transferrin receptor
involves the action of activated protein kinase C and an intact cytoskeleton. Proc.
Natl. Acad. Sd. USA, 260:9419-9426, 1985.
52. May, W. S., Sahyoun, N., Wolf, M., and Cuatrecasas, P. Role of intracellular
calrium mobilization in the regulation of protein kinase C-mediated membrane
processes. Nature, 317:549-551, 1985.
53. Klausner, R. D., Harford, J., and van Renswoude, J. Rapid internalization of
the transferrin receptor in K562 cells is triggered by ligand binding or treatment
with a phorbol ester. Proc. Natl. Acad. Sd. USA, 81:3005-3009, 1984.
54. Rothenberg, S., lacopetta, B. J., and Kuhn, L. C. Endocytosis of the
transferrin receptor requires the cytoplasmic domain but not its phosphorylation
site. Cell, 49:423-431, 1987.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

183
55. Zerial, M., Suomalainen, M., Zanetti-Schneider, M., Schneider, C., and Garoff,
H. Phosphorylation of the human transferrin receptor by protein kinase C is not
required for endocytosis and recycling in mouse 3T3 cells. EMBO J., 6:2661*2667,
1987.
56. McGraw, T. E., Dunn, K. W., and Maxfield, F. R. Phorbol ester treatment
increases the exocytic rate of the transferrin receptor recycling pathway
independent of serine-24 phosphorylation. J. Cell Biol., 106:1061-1066, 1988.
57. Kuhn, L. C., McClelland, A., and Ruddle, F. H. Gene transfer, expression,
and molecular cloning of the human transferrin receptor gene. Cell, 37:95-103,
1984.
58. McClelland, A., Kuhn, L. C., and Ruddle, F. H. The human transferrin
receptor gene: genomic organization, and the complete primary structure of the
receptor deduced from a cDNA sequence. Cell, 39:267-274, 1984.
59. Schneider, C., Owen, M. J., Banville, D., and Williams, J. G. Primary
structure of human transferrin receptor deduced from the mRNA sequence.
Nature, 311:675-678, 1984.
60. Stearae, P. A., Pietersz, G. A., and Goding, J. W. cDNA cloning of the
murine transferrin receptor: sequence of trans-membrane and adjacent regions.
J. Immunol., 134:3474-3479, 1985.
61. Rao, K., Harford, J. B., Rouault, T., McClelland, A., Ruddle, F. H., and
Klausner, R. D. Transcriptional regulation by iron of the gene for the transferrin
receptor. Mol. Cell. Biol., 6:236-240, 1986.
62. Hirata, T., Bitterman, P. B., Momex, J., Crystal, R. G. Expression of the
transferrin receptor gene during the process of mononuclear phagocyte maturation.
J. Immunol., 136:1339-1345, 1986.
63. Ho, P. T. C., King, I., and Sartorelli, I. Transcriptional regulation of the
transferrin receptor in differentiating HL-60 leukemia cells. Biochem. Biophys.
Res. Commun., 138:995-1000, 1986.
64. Ho, P. T. C., Ishiguro, K , and Sartorelli, A. C. Regulation of the transferrin
receptor in myeloid and monocytic differentiation of HL-60 leukemia cells. Cancer
Res., 49:1989-1995, 1989.
65. Taetle, R., Ralph, S., Smedsrud, S., and Trowbridge, I. Regulation of
transferrin receptor expression in myeloid leukemia cells. Blood, 70:852-859, 1987.
66. Trepel, J. B., Colamonici, O. R., Kelly, K., Schwab, G., Watt, R. A., Sausville,
E. A., Jaffa, E. S., and Neckers, L. M. Transcriptional inactivation of c-myc and
the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells. Mol. Ceil.
Biol., 7:2644-2648, 1987.
67. Owen, D., and Kuhn, L. C. Noncoding 3’ sequences of the transferrin receptor
gene are required for mRNA regulation by iron. EMBO J., 6:1287-1293, 1987.

R ep ro d u ced with p erm ission of the copyright ow ner. Further reproduction prohibited w ithout p erm ission .

184

68. Mullner, E. W., Neupert, B., and Kuhn, L. C. A specific mRNA binding factor
regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA.
Cell, 58:373-382, 1989.
69. Casey, J. L., Hentze, M. W., Koeller, D. M., Caugbman, S. W., Rouault, T.,
Klausner, R. D., and Harford, J. B. Iron responsive elements: regulatory RNA
sequences that control mRNA levels and translation. Science, 240:924-928, 1988.
70. Mullner, E. W., and Kuhn, L. C. A stem-loop in the 3’ untranslated region
mediates iron-dependent regulation of transferrin receptor mRNA stability in the
cytoplasm. Cell, 53:815-825, 1988.
71. Miskimins, W. K., McClelland, A., Roberts, M. P., and Ruddle, F. H. Cell
proliferation and expression of the transferrin receptor gene: promoter sequence
homologies and protein interactions. J. Cell Biol., 103:1781-1788, 1986.
72. Casey, J. L., Di Jeso, B., Rao, K , Klausner, R. D., and Harford, J. B. Two
genetic loci participate in the regulation by iron of the gene for the human
transferrin receptor. Proc. Natl. Acad. Sci. USA, 85:1787-1791, 1988.
73. Lee, W., Haslinger, A., Karin, M., and Tjian, R. Activation of transcription
by two factors that bind promoter and enhancer sequences of the human
metallothionein gene. Nature, 325:368-372, 1987.
74. Zamecnik, P. C., and Stephenson, M. L. Inhibition of Rous sarcoma virus
replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl.
Acad. Sci. USA, 75:280-284, 1978.
75. Stephenson, M. L., and Zamecnik, P. C. Inhibition of Rous sarcoma viral
RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA,
75:285-288, 1978.
76. Stein, C. A., and Cohen, J. S. Antisense compounds: potential role in cancer
therapy. In V. T. De Vita, S. Heilman, and S. A. Rosenberg (eds.). Important
Advances in Oncology, 1989. Lippincott, Philadelphia, pp. 79-97, 1989.
77. Marcus-Sekura, C. J. Techniques for using antisense oligdeoxyribonucleotides
to study gene expression. Anal. Biochem., 172:289-295, 1988.
78. van der Krol, A. R., Mol, J. N. M., and Stuitje, A. R. Modulation of
eukaryotic gene expression by complementary RNA or DNA sequences.
Biotechniques, 6:958-976, 1988.
79. Zon, G. Oligonucleotide analogues as potential chemotherapeutic agents.
Pharmaceut. Res., 5:539-549, 1988.
80. Mizuno, T., Chou, M. Y., and Inouye, M. A unique mechanism regulating
gene expression: translational inhibition by a complementary RNA transcript
(micRNA). Proc. Natl. Acad. Sci. USA, 81:1966-1970, 1984.
81. Heywood, S. M. tcRNA as natural occurring antisense RNA in eukaryotes.
Nucleic Acids Res., 14:6771-6772, 1986.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

185
82. Izant, J. G., and Weintraub, H. Inhibition of thymidine kinase gene
expression by anti-sense RNA: a molecular approach io genetic analysis. Cell,
36:1007-1015, 1984.
83. Izant, J. G., and Weintraub, H. Constitutive and conditional suppression of
exogenous and endogenous genes by anti-sense RNA. Science, 229:345-352, 1985.
84. Melton, D. A. Injected anti-sense RNAs specifically block messenger RNA
translation in vivo. Proc. Natl. Acad. Sci. USA, 82:144-148, 1985.
85. Westin, E. H., Wong-Staal, F., Gelmann, E. P., Dalla Favera, R., Papas, T. S.,
Lautenberger, J. A., Eva, A., Reddy, E. P., Tronick, S. R., Aaronson, S. A., and
Gallo, R. C. Expression of cellular homologues of retroviral one genes in human
hematopoietic cells. Proc. Natl. Acad. Sci. USA, 79:2490-2494, 1982.
86. Dmitrovsky, E., Kuehl, W. M., Hollis, G. F., Kirsch, I. R., Bender, T. P., and
Segal, S.
Expression of a transfected human c-myc oncogene inhibits
differentiation of a mouse erythroleukemia cell line. Nature, 322:748-750, 1986.
87. Coppola, J. A., and Cole, M. D. Constituitive c-myc oncogene expression
blocks mouse erythroleukemia cell differentiation but not commitment. Nature,
320:760-763, 1986.
88. Yokoyama, K., and Imamoto, F. Transcriptional control of endogenous myc
protooncogene by antisense RNA. Proc. Natl. Acad. Sci. USA, 84:7363-7367, 1987.
89. Caruthers, M. Gene synthesis machines:
Science, 230:281-285, 1985.

DNA chemistry and its uses.

90. Powers, G. J., Jones, R. L., Randall, G. A., Caruthers, M. H., van de Sande,
J. H., and Khorana, H. G. Optimal strategies for the chemical and enzymatic
synthesis of bihelical deoxyribonucleic acids. J. Am. Chem. Soc., 97:875-884, 1975.
91. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H.,
and Wickstrom, E. Human promyelocytic leukemia HL-60 cell proliferation and cmyc protein expression are inhibited by an antisense pentadecadeoxynucleotide
targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA, 85:1028-1032, 1988.
92. Holt, J. T., Redner, R. L., and Nienhuis, A. W. An oligomer complementary
to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces
differentiation. Mol. Cell. Biol., 8:963-973, 1988.
93. Heikkila, R., Schwab, G., Wickstrom, E., Loke, S. L., Pluznik, D. H., Watt, R.,
and Neckers, L. M. A c-myc antisense oligodeoxynucleotide inhibits entry into S
phase but not progress from G0 to G,. Nature, 328:445-449, 1987.
94. Harel-Bellan, A., Ferris, D. K., Vinocour, M., Holt, J. T., and Farrar, W. L.
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxyoligonucleotide in human T lymphocytes. J. Immunol., 140:2431-2435, 1988.
95. Gewirtz, A. M., and Calabretta, B. A c-myb antisense oligodeoxynucleotide
inhibits normal human hematopoiesis in vitro. Science, 242:1303-1306, 1988.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

186

96. Anfossi, G., Gewirtz, A. M., and Calabretta, B. An oligomer complementary
to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell
lines. Proc. Natl. Acad. Sci. USA, 86:3379-3383, 1989.
97. Gewirtz, A. M., Anfossi, G., Venturelli, D., Valpreda, S., Sims, R., and
Calabretta, B. Gl/S transition of normal human T-lymphocytes requires the
nuclear protein encoded by c-myb. Science, 245:180-183, 1989.
98. Jaskulsi, D., DeRiel, J. K., Mercer, W. E., Calabretta, B., and Baserga, R.
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA
cyclin. Science, 240:1544-1546, 1988.
99. Maher, L. J., and Dolnick, B. J. Specific hybridization arrest of dihydrofolate
reductase mRNA in vitro using anti-sense RNA or anti-sense oligonucleotides.
Arch. Biochem. Biophys., 253:214-220, 1987.
100. Wickstrom, E. Oligodeoxynucleotide stability in subcellular extracts and
culture media. J. Biochem. Biophys. Methods, 13:97-102, 1986.
101. Miller, P. S., Yano, J., Yano, E., Carroll, C., Jayaraman, K., and Ts’o, P. O.
P.
Nonionic nucleic acid analogues.
Synthesis and characterization of
dideoxyribonucleoside methylphosphonates. Biochemistry, 18:5134-5143, 1979.
102. Miller, P. S., McFarland, K. B., Jayaraman, K., and Ts’o, P. O. P.
Biochemical and biological effects of nonionic nucleic acid methylphosphonates.
Biochemistry, 20:1874-1880, 1981.
103. Stein, C. A., and Cohen, J. S. Oligodeoxynucleotides as inhibitors of gene
expression: a review. Cancer Res., 48:2659-2668, 1988.
104. Froehler, B. C. Deoxynucleoside H-phosphonate diester intermediates in the
synthesis of intemucleotide phosphate analogues. Tetrahedron Lett., 27:55755578, 1986.
105. Stein, C. A., Subasinghe, C., Shinozuka, K., and Cohen, J. S.
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids
Res., 16:3209-3221, 1988.
106. Marcus-Sekura, C. J., Woemer, A. M., Shinozuka, K., Zon, G., and Quinnan,
G. V. Comparative inhibition of chloramphenicol acetyltransferase gene expression
by antisense oligonucleotide analogues having alkyl phosphotriester,
methylphosphonate and phosphorothioate linkages. Nucleic Acids Res., 15:57495763, 1987.
107. Cazenave, C., Stein, C. A., Loreau, N., Thuong, N. T., Neckers, L. M.,
Subasinghe, C., Helene, C., Cohen, J. S., and Toulme, J. J. Comparative inhibition
of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.
Nucleic Acids Res., 17:4255-4273, 1989.

R ep ro d u ced with p erm ission of th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

187
108. Asseline, U., Delarue, M., Lancelot, G., Toulme, F., Thuong, N. T., MontenayGarestier, T., and Helene, C. Nudeic add-binding molecules with high affinity and
base sequence sperifirity; intercalation agents covalently linked to
oligodeoxynucleotides. Proc. Natl. Acad. Sd. USA, 81:3-297-3301, 1984.
109. Toulme, J., Krisch, H., Loreau, N., and Helene, C. Spedfic inhibition of
mRNA translation by complementary oligonudeotides covalently linked to
intercalating agents. Proc. Natl. Acad. Sd. USA, 83:1227-1231, 1986.
110. Dreyer, G., and Dervan, P. Sequence-specific cleavage of single stranded
DNA: oligodeoxynucleotide-EDTA:Fe(II). Proc. Natl. Acad. Sd. USA, 82:968-972,
1985.
111. Francois, J. C., Saison-Behmoaras, T., Chassignol, M., Thuong, N. T., and
Helene, C. Sequence-targeted cleavage of single- and double-stranded DNA by
oligothymidylates covalently linked to 1,10-phenanthroline.
J. Biol. Chem.,
264:5891-5898, 1989.
112. Zamecnik, P. C., Goodchild, J., Taguchi, Y., and Sarin, P. S. Inhibition of
replication and expression of human T-cell lymphotropic virus type III in cultured
cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc.
Natl. Acad. Sci. USA, 83:4143-4146, 1986.
113. Goodchild, J., Agrawal, S., Civeira, M. P., Sarin, P. S., Sun, D., and
Zamecnik, P. C. Inhibition of human immunodefidency virus replication by
antisense oligodeoxynucleotides. Proc. Natl. Acad. Sd. USA, 85:5507-5511, 1988.
114. Smith, C. C., Aurelian, L., Reddy, M. P., Miller, P. S., and Ts’o, P. O. P.
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the
splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and
5. Proc. Natl. Acad. Sd. USA, 83:2787-2791, 1986.
115. Agris, C. H., Blake, K R., Miller, P. S., Reddy, M. P., and Ts’o P. O. P.
Inhibition of vesicular stomatitis virus protein synthesis and infection by sequencespecific oligodeoxyribonucleoside methylphosphonates. Biochemistry, 25:6268-6275,
1986.
116. Sarin, P. S., Agrawal, S., Civeira, M. P., Goodchild, J., Ikeuchi, T., and
Zamecnik, P. C. Inhibition of acquired immunodefidency syndrome virus by
oligodeoxynucleoside methylphosphonates. Proc. Natl. Acad. Sci. USA, 85:74487451, 1988.
117. Matsukura, M., Shinozuka, K , Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S.,
and Broder, S. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of
replication and cytopathic effects of human immunodefidency virus. Proc. Natl.
Acad. Sd. USA, 84:7706-7710, 1987.
118. Gao, W., Stein, C. A., Cohen, J. S., Dutschman, G. E., and Cheng, Y. C.
Effect of phosphorothioate homo-oligodeoxynucleotides on Herpes Simplex Virus
type 2-induced DNA polymerase. J. Biol. Chem., 264:11521-11526, 1989.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

188
119. Matsukura, M., Zon, G., Shinozuka, Z., Robert-Guroff, M., Shimada, T., Stein,
C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S., and Broder, S. Regulation of
viral expression of human immunodeficiency virus in vitro by an anti-sense
phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected
cells. Proc. Natl. Acad. Sci. USA, 86:4244-4248, 1989.
120. Agrawal, S., Goodchild, J., Civeira, M. P., Thornton, A. H., Sarin, P. S., and
Zamecnik, P. C. Oligodeoxynucleoside phosphoramidates and phosphorothioates as
inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 85:70797083, 1988.
121. Walder, R. Y., and Walder, J. A.
translation by antisense oligonucleotides.
5015, 1988.

Role of RNase H in hybrid-arrested
Proc. Natl. Acad. Sd. USA, 85:5011-

122. Rqjogopal, P., and Feigon, J.
Triple-strand formation in the
homopurine:homopyrimidine DNA oligonucleotides d(G-A)4 and d(T-C)4. Nature,
339:637-640, 1989.
123. Cooney, M., Czemuszewicz, G., Postel, E. H., Flint, S. J., and Hogan, M. E.
Site-spedfic oligonucleotide binding represses transcription of the human c-myc
gene in vitro. Sdence, 241:456-459, 1988.
124. Maher, L. J., Wold, B., and Dervan, P. B. Inhibition of DNA binding
proteins by oligonucleotide-directed triple helix formation. Sdence, 245:725-730,
1989.
125. Yam, L. T., Li, C. Y., and Crosby, W. M. Cytochemical identification of
monocytes and granulocytes. Am. J. Clin. Path., 55:283-290, 1971.
126. Crissman, H. A., Oka, M. S., and Steinkemp, J. A. Rapid staining methods
for analysis of deoxyribonucleic add and protein in mammalian cells. J.
Histochem. Cytochem., 24:64-71, 1976.
127. Bates, G. W., and Schlabach, M. R. The reaction of ferric salts with
transferrin. J. Biol. Chem., 248:3228-3232, 1973.
128. Harris, D. C., and Aisen, P.
Biochemistry, 14:262-268, 1975.

Iron donating properties of transferrin.

129. Louache, F., Testa, V., Pelicd, P., Thomopoulos, P., Titeux, M., and Rochant,
H. Regulation of transferrin receptors in human hematopoietic cell lines. J. Biol.
Chem., 259:11576-11582, 1984.
130. Laemmli, U. K. Cleavage of structural proteins dining assembly of the head
of bacteriophage T4. Nature, 227:680-685, 1970.
131. Chirwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J.
Isolation of biologically active ribonucleic acid from sources enriched in
ribonuclease. Biochemistry, 18:5294-5299, 1979.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

189
132. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci.
USA, 81:1991-1995, 1984.
133. Feinberg, A. P., and Vogelstein, B. A technique for radiolabelling DNA
restriction endonuclease fragments to high specific activity. Anal. Biochem., 132:613, 1983.
134. Cleveland, D. W., Lopata, M. A., MacDonald, R. J., Cowan, N. J., Rutter,
W. J., and Kirschner, M. W. Number and evolutionary conservation of a- and 6tubulin and cytoplasmic fi- and gamma-actin genes using specific cloned cDNA
probes. Cell, 20:95-105, 1980.
135. Lo, K. M., Jones, S. S., Hackett, N. R., and Khorana, H. G. Specific amino
acid substitutions in bacteriopsin: replacement of a restriction fragment in the
structural gene by synthetic DNA fragments containing altered codons. Proc. Natl.
Acad. Sci. USA, 81:2285-2289, 1984.
136. Froehler, B. C., and Matteucci, M. D. Nucleoside H-phosphonates: valuable
intermediates in the synthesis of deoxyoligonucleotides. Tetrahedron Letters
27:469-472, 1986.
137. Froehler, B. C., Ng, P. G., and Matteucci, M. D. Synthesis of DNA via
deoxyrihonucleoside H-phosphonate intermediates. Nucleic Acids Res. 14:53995407, 1986.
138. Garegg, P. J., Lindh, I., Regberg, T., Stawinski, J., and Stromberg, R.
Nucleoside H-phosphonates. III. Chemical synthesis of oligodeoxyribonucleotides
by the hydrogen-phosphonate approach. Tetrahedron Letters 27:4051-4057, 1986.
139. "Oligonucleotide synthesis with hydrogen-phosphonate monomers."
Biosystems User Bulletin No. 44, 1987.

Applied

140. Gladhaug, I. P., Refsnes, M., Sand, T. E., and Christoffersen, T. Effects of
butyrate on epidermal growth factor receptor binding, morphology, and DNA
synthesis in cultured rat hepatocytes. Cancer Res., 48:6560-6564, 1988.
141. May, W. S., Sahyoun, N., Jacobs, S., Wolf, M., and Cuatrecasas, P.
Mechanism of phorbol diester-induced regulation of surface transferrin receptor
involves the action of activated protein kinase C and an intact cytoskeleton. Proc.
Natl. Acad. Sci. USA, 260:9419-9426, 1985.
142. Koretsky, G. A., Danielle, R. P., Greene, W. C., and Nowell, P. C. Evidence
for an interleukin-independent pathway for human lymphocyte activation. Proc.
Natl. Acad. Sci. USA, 80:3444-3447, 1983.
143. Neckers, L. M., Bauer, S., McGlennen, R. C., Trepel, J. B., Rao, K., and
Greene, W. C. Diltiazem inhibits transferrin receptor expression and causes G,
arrest in normal and neoplastic T cells. Mol. Cell. Biol., 6:4244-4250, 1986.
144. £ucker, M., and Steigler, P. Optimal computer folding of large RNA
sequences using thermodynamics and auxiliary information. Nucleic Acids Res.
9:133-148, 1981.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

190
145. Frier, S. M., Kierzek, R., Jaeger, J. A., Sugimoto, M., Caruthers, M. H.,
Nielson, T., and Turner, D. H. Improved free energy parameters for predictions
of RNA duplex stability. Proc. Natl. Acad. Sci. USA, 83:9373*9377, 1986.
146. "The evaluation and purification of synthetic oligonucleotides."
Biosystems User Bulletin No. 13-Revised, 1987.

Applied

147. Wickstrom, E. Oligodeoxynucleotide stability in subcellular extracts and
culture media. J. Biochem. Biophys. Methods, 13:97*102, 1988.
148. Ho, P. T. C., Ishiguro, K., Wickstrom, E., and Sartorelli, A. C. Inhibition
of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate
antisense oligonudectides. Manuscript in preparation.
149. O’Keefe, S. J., Wolfes, H., Kiessling, A. A., and Cooper, G. M. Microinjection
of antisense c-mos oligonudectides prevents meiosis II in the maturing mouse egg.
Proc. Natl. Acad. Sd. USA, 86:7038-7042, 1989.
150. Letsinger, R. L., Xhang, G., Sun, D. K , Ikeuchi, T., and Sarin, P. S.
Choiesteryl-conjugated oligonucleotides: synthesis, properties, and activity as
inhibitors of replication of human immunodefidency virus in culture. Proc. Natl.
Acad. Sd. USA, 86:6553*6556, 1989.
151. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Lyman, G. H., and Wickstrom
E. Anti-c-myc DNA increases differentiation and decreases colony formation by HL60 cells. In Vitro Cellular and Developmental Biol., 24:207-302, 1989.
152. Letsinger, R. L., Xhang, G., Sun, D. K., Ikeuchi, T., and Sarin, P. S.
Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as
inhibitors of replication of human immunodefidency virus in culture. Proc. Natl.
Acad. Sd. USA, 86:6553-6556, 1989.
153. Spitzer, S., and Eckstein, F.
Inhibition of deoxyribonudeases by
phosphorothioate groups in oligodeoxyribonucleotides. Nucleic Adds Res. 16:1169111704, 1988.
154. Loke, S. L., Stein, C. A., Zhang, X. H., Nakanishi, M., Subasinghe, C., Cohen,
J. S., and Neckers, L. M. Characterization of oligonucleotide transport into living
cells. Proc. Natl. Acad. Sd. USA 86:3474-3478, 1989.
155. Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S.,
Yurchenko, L. V., and Vlassov, V. V. Mechanism of oligonudeotide uptake by cells:
involvement of spedfic receptors? Proc. Natl. Acad. Sd. USA 86:6454-6458, 1989.
156. Belikova, A. M., Zarytova, V. F., and Grineva, N. I. Synthesis of
ribonucleosides and diribonudeoside phosphates containing 2-chloroethylamine and
nitrogen mustard residues. Tetrahedron Letters, 37:3557-3362, 1967.
157. Grineva, N. I., and Karpova, G. G. Complementarily addressed modification
of rRNA with p-(chloroethylmethylamino)benzylidene hexanucleotides. FEBS
Letters, 82:351-355, 1973.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

